doi|doi|FW :|:|: 10.1093|10.1093|CD /|/|SYM mutage|mutage|NN /|/|SYM gep026|gep026|NN Mutagenesis|mutagenesis|NN vol|vol|NN .|.|. 
24|24|CD no.|no.|NN 5|5|CD pp.|pp.|RB 433|433|CD --|--|: 438|438|CD ,|,|, 2009|2009|CD Advance|Advance|NNP Access|Access|NNP Publication|publication|NN 6|6|CD July|July|NNP 2009|2009|CD Inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN using|use|VBG 10|10|CD model|model|NN chemicals|chemical|NNS of|of|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutation|mutation|NN assay|assay|NN Joel|Joel|NNP Ackerman|Ackerman|NNP *|*|NFP ,|,|, Rahul|Rahul|NNP Sharma|Sharma|NNP ,|,|, Jonathan|Jonathan|NNP Hitchcock|Hitchcock|NNP ,|,|, 1|1|CD 2|2|CD Toshiaki|Toshiaki|NNP Hayashi|Hayashi|NNP ,|,|, Yoshikazu|Yoshikazu|NNP Nagai|Nagai|NNP ,|,|, Shuanglian|Shuanglian|NNP Li|Li|NNP ,|,|, 3|3|CD 3|3|CD 4|4|CD Shuyan|Shuyan|NNP Lu|Lu|NNP ,|,|, Juan|Juan|NNP Miret|Miret|NNP ,|,|, Kim|Kim|NNP Tang|Tang|NNP ,|,|, Fiona|Fiona|NNP Spence|Spence|NNP and|and|CC 4|4|CD 1|1|CD 1|1|CD 2|2|CD Jiri|Jiri|NNP Aubrecht|Aubrecht|NNP Pﬁzer|Pﬁzer|NNP Global|Global|NNP Research|Research|NNP and|and|CC Development|Development|NNP ,|,|, Drug|Drug|NNP Safety|Safety|NNP Research|Research|NNP and|and|CC Development|Development|NNP ,|,|, Eastern|Eastern|NNP Point|Point|NNP Road|Road|NNP ,|,|, Groton|Groton|NNP ,|,|, CT|CT|NNP 06340|06340|CD ,|,|, USA|USA|NNP ,|,|, Research|Research|NNP 1|1|NNP Technology|Technology|NNP Center|Center|NNP ,|,|, Cambridge|Cambridge|NNP ,|,|, MA|MA|NNP 02139|02139|CD ,|,|, USA|USA|NNP ,|,|, Drug|Drug|NNP Safety|Safety|NNP Research|Research|NNP 2|2|CD and|and|CC Development|Development|NNP ,|,|, Sandwich|Sandwich|NNP ,|,|, Kent|Kent|NNP ,|,|, Great|Great|NNP Britain|Britain|NNP CT13|ct13|NN 9NJ|9nj|NN ,|,|, UK|UK|NNP ,|,|, Drug|Drug|NNP 3|3|CD Safety|Safety|NNP Research|Research|NNP and|and|CC Development|Development|NNP (|(|-LRB- Nagoya|Nagoya|NNP Laboratories|Laboratories|NNP )|)|-RRB- ,|,|, 5|5|CD -|-|SYM 2|2|CD Taketoyo|Taketoyo|NNP ,|,|, Aichi|Aichi|NNP 4|4|CD 470-2393|470-2393|CD ,|,|, Japan|Japan|NNP and|and|CC Drug|Drug|NNP Safety|Safety|NNP Research|Research|NNP and|and|CC Development|Development|NNP ,|,|, La|La|NNP Jolla|Jolla|NNP ,|,|, CA|CA|NNP 92121|92121|CD ,|,|, USA|USA|NNP We|we|PRP have|have|VBP developed|develop|VBN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutation|mutation|NN assay|assay|NN as|as|IN a|a|DT tool|tool|NN for|for|IN detecting|detect|VBG mutagenicity|mutagenicity|NN applicable|applicable|JJ for|for|IN high|high|JJ -|-|HYPH throughput|throughput|NN screening|screening|NN of|of|IN new|new|JJ chemicals|chemical|NNS .|.|. 
In|in|IN this|this|DT study|study|NN ,|,|, we|we|PRP report|report|VBP the|the|DT inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN of|of|IN the|the|DT assay|assay|NN using|use|VBG 10|10|CD model|model|NN chemicals|chemical|NNS in|in|IN ﬁve|ﬁve|NN independent|independent|JJ laboratories|laboratory|NNS located|locate|VBN in|in|IN the|the|DT USA|USA|NNP (|(|-LRB- Groton|Groton|NNP ,|,|, CT|ct|NN ;|;|: Cambridge|Cambridge|NNP ,|,|, MA|MA|NNP and|and|CC La|La|NNP Jolla|Jolla|NNP ,|,|, CA|CA|NNP )|)|-RRB- ,|,|, Europe|Europe|NNP (|(|-LRB- Sandwich|Sandwich|NNP ,|,|, Kent|Kent|NNP ,|,|, UK|UK|NNP )|)|-RRB- and|and|CC Asia|Asia|NNP (|(|-LRB- Nagoya|Nagoya|NNP ,|,|, Japan|Japan|NNP )|)|-RRB- .|.|. 
The|the|DT studies|study|NNS were|be|VBD performed|perform|VBN in|in|IN blinded|blinded|JJ fashion|fashion|NN in|in|IN all|all|DT sites|site|NNS except|except|IN for|for|IN Groton|Groton|NNP and|and|CC Cambridge|Cambridge|NNP laboratories|laboratory|NNS .|.|. 
The|the|DT chemicals|chemical|NNS were|be|VBD tested|test|VBN in|in|IN at|at|IN least|least|RBS three|three|CD independent|independent|JJ experiments|experiment|NNS using|use|VBG strains|strain|NNS TA98|ta98|NN -|-|HYPH lux|lux|NN and|and|CC TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN and|and|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN .|.|. 
The|the|DT results|result|NNS were|be|VBD statistically|statistically|RB evaluated|evaluate|VBN and|and|CC compared|compare|VBN to|to|IN published|publish|VBN results|result|NNS .|.|. 
Seven|seven|CD of|of|IN the|the|DT 10|10|CD compounds|compound|NNS were|be|VBD positive|positive|JJ in|in|IN either|either|CC TA98|ta98|NN -|-|HYPH lux|lux|NN and|and|CC /|/|HYPH or|or|CC TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN or|or|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN .|.|. 
The|the|DT positive|positive|JJ compound|compound|NN set|set|NN included|include|VBD :|:|: nitrofurazone|nitrofurazone|NN ,|,|, 3|3|CD -|-|SYM 3|3|CD #|#|SYM -|-|HYPH dimethoxybenzidine|dimethoxybenzidine|NN ,|,|, benzo|benzo|NN [|[|-LRB- a|a|DT ]|]|-RRB- pyrene|pyrene|NN ,|,|, 1,4|1,4|CD -|-|HYPH benzoquinone|benzoquinone|NN dioxime|dioxime|NN ,|,|, 2|2|CD -|-|HYPH amino|amino|NN -5-nitrophenol|-5-nitrophenol|NN ,|,|, 2|2|CD -|-|HYPH bromo|bromo|NN -|-|HYPH 4|4|CD ,6|,6|NN -|-|HYPH dinitroaniline|dinitroaniline|NN and|and|CC busulfan|busulfan|NN .|.|. 
The|the|DT remaining|remain|VBG three|three|CD compounds|compound|NNS ,|,|, namely|namely|RB ,|,|, anthracene|anthracene|NN ,|,|, crystal|crystal|NN violet|violet|NN and|and|CC benzyl|benzyl|NN chloride|chloride|NN were|be|VBD negative|negative|JJ in|in|IN both|both|CC Salmonella|salmonella|NN strains|strain|NNS .|.|. 
Final|final|JJ results|result|NNS for|for|IN individual|individual|JJ compounds|compound|NNS yielded|yield|VBD 100|100|CD %|%|NN agreement|agreement|NN among|among|IN the|the|DT laboratories|laboratory|NNS and|and|CC published|publish|VBN data|datum|NNS .|.|. 
Detailed|detailed|JJ comparison|comparison|NN of|of|IN all|all|RB 40|40|CD individual|individual|JJ test|test|NN conditions|condition|NNS yielded|yield|VBD 93|93|CD %|%|NN (|(|-LRB- 37|37|CD of|of|IN 40|40|CD )|)|-RRB- agreement|agreement|NN among|among|IN participating|participate|VBG laboratories|laboratory|NNS .|.|. 
We|we|PRP conclude|conclude|VBP that|that|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutation|mutation|NN assay|assay|NN is|be|VBZ a|a|DT robust|robust|JJ ,|,|, accurate|accurate|JJ and|and|CC economical|economical|JJ higher|higher|JJR throughput|throughput|NN assay|assay|NN applicable|applicable|JJ for|for|IN the|the|DT mutagenicity|mutagenicity|NN screening|screening|NN of|of|IN chemicals|chemical|NNS .|.|. 
The|the|DT development|development|NN of|of|IN relevant|relevant|JJ high|high|JJ -|-|HYPH throughput|throughput|NN screening|screening|NN technologies|technology|NNS to|to|TO assess|assess|VB safety|safety|NN of|of|IN lead|lead|NN compounds|compound|NNS at|at|IN the|the|DT early|early|JJ stages|stage|NNS of|of|IN drug|drug|NN discovery|discovery|NN is|be|VBZ extremely|extremely|RB important|important|JJ for|for|IN identifying|identify|VBG safe|safe|JJ lead|lead|NN chemicals|chemical|NNS and|and|CC /|/|HYPH or|or|CC series|series|NN .|.|. 
Since|since|IN its|its|PRP$ discovery|discovery|NN in|in|IN the|the|DT early|early|JJ 1970s|1970|NNS by|by|IN Ames|Ames|NNP et|et|FW al.|al.|FW (|(|-LRB- 1|1|CD )|)|-RRB- ,|,|, the|the|DT Salmonella|Salmonella|NNP reverse|reverse|JJ mutation|mutation|NN plate|plate|NN incorporation|incorporation|NN assay|assay|NN has|have|VBZ been|be|VBN widely|widely|RB used|use|VBN to|to|TO detect|detect|VB the|the|DT mutagenic|mutagenic|JJ activity|activity|NN of|of|IN drug|drug|NN candidates|candidate|NNS and|and|CC environmental|environmental|JJ chemicals|chemical|NNS .|.|. 
The|the|DT Salmonella|Salmonella|NNP assay|assay|NN ,|,|, commonly|commonly|RB referred|refer|VBN to|to|IN as|as|IN the|the|DT Ames|Ames|NNP assay|assay|NN ,|,|, was|be|VBD validated|validate|VBN by|by|IN the|the|DT testing|testing|NN of|of|IN several|several|JJ hundred|hundred|CD chemicals|chemical|NNS through|through|IN a|a|DT programme|programme|NN sponsored|sponsor|VBN by|by|IN the|the|DT National|National|NNP Toxicology|Toxicology|NNP Program|Program|NNP (|(|-LRB- NTP|NTP|NNP )|)|-RRB- (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- .|.|. 
Positive|positive|JJ responses|response|NNS in|in|IN the|the|DT Salmonella|Salmonella|NNP reverse|reverse|JJ mutation|mutation|NN assay|assay|NN have|have|VBP a|a|DT good|good|JJ correlation|correlation|NN with|with|IN the|the|DT outcome|outcome|NN of|of|IN rodent|rodent|NN carcinogenicity|carcinogenicity|NN testing|testing|NN (|(|-LRB- 7,8|7,8|CD )|)|-RRB- .|.|. 
As|as|IN the|the|DT results|result|NNS of|of|IN the|the|DT Salmonella|Salmonella|NNP assay|assay|NN are|be|VBP required|require|VBN by|by|IN regulatory|regulatory|JJ agencies|agency|NNS for|for|IN drug|drug|NN approvals|approval|NNS worldwide|worldwide|RB (|(|-LRB- 9|9|CD )|)|-RRB- ,|,|, a|a|DT positive|positive|JJ Ames|Ames|NNP result|result|NN in|in|IN the|the|DT Salmonella|Salmonella|NNP assay|assay|NN frequently|frequently|RB stops|stop|VBZ development|development|NN particularly|particularly|RB if|if|IN these|these|DT compounds|compound|NNS are|be|VBP intended|intend|VBN for|for|IN the|the|DT treatment|treatment|NN of|of|IN non-life|non-life|JJ threatening|threatening|JJ diseases|disease|NNS or|or|CC disorders|disorder|NNS (|(|-LRB- 10|10|CD )|)|-RRB- .|.|. 
In|in|IN brief|brief|JJ ,|,|, the|the|DT Salmonella|Salmonella|NNP reverse|reverse|JJ mutation|mutation|NN assay|assay|NN detects|detect|VBZ reversions|reversion|NNS of|of|IN auxotrophic|auxotrophic|JJ mutations|mutation|NNS in|in|IN Salmonella|Salmonella|NNP typhimu|typhimu|NN -|-|HYPH rium|rium|NN ,|,|, which|which|WDT either|either|CC are|be|VBP base|base|JJ -|-|HYPH pair|pair|NN substitution|substitution|NN or|or|CC frame|frame|NN shift|shift|NN mutations|mutation|NNS in|in|IN histidine|histidine|NN synthesis|synthesis|NN pathway|pathway|NN genes|gene|NNS .|.|. 
Such|such|JJ histidine|histidine|NN -|-|HYPH dependent|dependent|JJ cells|cell|NNS are|be|VBP not|not|RB capable|capable|JJ of|of|IN synthesizing|synthesize|VBG endogenous|endogenous|JJ histidine|histidine|NN which|which|WDT results|result|VBZ in|in|IN no|no|DT growth|growth|NN in|in|IN histidinefree|histidinefree|NN media|media|NNS .|.|. 
A|a|DT reverse|reverse|JJ mutation|mutation|NN that|that|WDT restores|restore|VBZ endogenous|endogenous|JJ histidine|histidine|NN biosynthesis|biosynthesis|NN enables|enable|VBZ bacterial|bacterial|JJ growth|growth|NN even|even|RB in|in|IN the|the|DT absence|absence|NN of|of|IN exogenous|exogenous|JJ histidine|histidine|NN (|(|-LRB- histidine|histidine|NN -|-|HYPH independent|independent|JJ cells|cell|NNS )|)|-RRB- .|.|. 
In|in|IN the|the|DT standard|standard|JJ Ames|Ames|NNP assay|assay|NN ,|,|, the|the|DT treatment|treatment|NN of|of|IN histidine|histidine|NN -|-|HYPH dependent|dependent|JJ cells|cell|NNS with|with|IN mutagens|mutagen|NNS leads|lead|VBZ to|to|IN an|a|DT increased|increase|VBN number|number|NN of|of|IN bacterial|bacterial|JJ revertants|revertant|NNS (|(|-LRB- histidine|histidine|NN -|-|HYPH independent|independent|JJ cells|cell|NNS )|)|-RRB- detected|detect|VBN as|as|IN colonies|colony|NNS over|over|IN a|a|DT background|background|NN lawn|lawn|NN of|of|IN histidine|histidine|NN -|-|HYPH dependent|dependent|JJ cells|cell|NNS .|.|. 
Despite|despite|IN the|the|DT relative|relative|JJ simplicity|simplicity|NN of|of|IN the|the|DT standard|standard|JJ Salmonella|Salmonella|NNP reverse|reverse|JJ mutation|mutation|NN assay|assay|NN ,|,|, its|its|PRP$ application|application|NN as|as|IN a|a|DT screening|screening|NN tool|tool|NN in|in|IN the|the|DT early|early|JJ phases|phase|NNS of|of|IN drug|drug|NN discovery|discovery|NN is|be|VBZ not|not|RB feasible|feasible|JJ due|due|IN to|to|IN a|a|DT lack|lack|NN of|of|IN high|high|JJ -|-|HYPH throughput|throughput|NN attributes|attribute|NNS .|.|. 
Several|several|JJ attempts|attempt|NNS to|to|TO miniaturize|miniaturize|VB the|the|DT Ames|Ames|NNP assay|assay|NN ,|,|, such|such|JJ as|as|IN the|the|DT Spiral|spiral|JJ assay|assay|NN ,|,|, Miniscreen|Miniscreen|NNP ,|,|, Mutascreen|Mutascreen|NNP ,|,|, and|and|CC Ames|Ames|NNP II|II|NNP assays|assay|NNS ,|,|, have|have|VBP been|be|VBN published|publish|VBN (|(|-LRB- 11|11|CD --|--|: 15|15|CD )|)|-RRB- .|.|. 
Although|although|IN Spiral|spiral|JJ and|and|CC Miniscreen|Miniscreen|NNP have|have|VBP been|be|VBN applied|apply|VBN in|in|IN drug|drug|NN discovery|discovery|NN settings|setting|NNS (|(|-LRB- 16,17|16,17|CD )|)|-RRB- ,|,|, their|they|PRP$ use|use|NN is|be|VBZ limited|limit|VBN due|due|IN to|to|IN cumbersome|cumbersome|JJ methods|method|NNS to|to|TO detect|detect|VB revertants|revertant|NNS ,|,|, relatively|relatively|RB high|high|JJ compound|compound|NN requirements|requirement|NNS ,|,|, low|low|JJ throughput|throughput|NN and|and|CC low|low|JJ potential|potential|NN for|for|IN automation|automation|NN .|.|. 
We|we|PRP have|have|VBP recently|recently|RB reported|report|VBN the|the|DT development|development|NN of|of|IN the|the|DT bioluminescent|bioluminescent|JJ reverse|reverse|JJ mutation|mutation|NN assay|assay|NN in|in|IN Salmonella|Salmonella|NNP as|as|IN a|a|DT higher|higher|JJR throughput|throughput|NN platform|platform|NN applicable|applicable|JJ for|for|IN the|the|DT screening|screening|NN of|of|IN large|large|JJ sets|set|NNS of|of|IN the|the|DT compounds|compound|NNS (|(|-LRB- 18|18|CD )|)|-RRB- .|.|. 
The|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN assay|assay|NN utilizes|utilize|VBZ genetically|genetically|RB engineered|engineer|VBN standard|standard|JJ Ames|Ames|NNP Salmonella|Salmonella|NNP tester|tester|NN strains|strain|NNS TA98|ta98|NN and|and|CC TA100|ta100|NN expressing|express|VBG the|the|DT lux|lux|NN (|(|-LRB- CDABE|CDABE|NNP )|)|-RRB- operon|operon|NN from|from|IN Xenorhabdus|Xenorhabdus|NNP luminescens|luminescen|NNS .|.|. 
The|the|DT assay|assay|NN employs|employ|VBZ bioluminescence|bioluminescence|NN as|as|IN a|a|DT sensor|sensor|NN of|of|IN changes|change|NNS in|in|IN bacterial|bacterial|JJ metabolism|metabolism|NN associated|associate|VBN with|with|IN starvation|starvation|NN effectively|effectively|RB identifying|identify|VBG colonies|colony|NNS of|of|IN histidine|histidine|NN -|-|HYPH dependent|dependent|JJ revertant|revertant|NN cells|cell|NNS .|.|. 
The|the|DT bioluminescent|bioluminescent|JJ Sal|Sal|NNP -|-|HYPH monella|monella|NNP assay|assay|NN provides|provide|VBZ an|a|DT economical|economical|JJ ,|,|, higher|higher|JJR throughput|throughput|NN tool|tool|NN for|for|IN assessment|assessment|NN of|of|IN mutagenicity|mutagenicity|NN with|with|IN high|high|JJ concordance|concordance|NN to|to|IN outcomes|outcome|NNS in|in|IN the|the|DT current|current|JJ Ames|Ames|NNP standard|standard|NN plate|plate|NN incorporation|incorporation|NN method|method|NN (|(|-LRB- 18|18|CD )|)|-RRB- .|.|. 
In|in|IN this|this|DT study|study|NN ,|,|, we|we|PRP present|present|VBP an|a|DT inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN of|of|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN assay|assay|NN that|that|WDT consisted|consist|VBD of|of|IN the|the|DT evaluation|evaluation|NN of|of|IN 10|10|CD well|well|RB -|-|HYPH characterized|characterize|VBN model|model|NN agents|agent|NNS by|by|IN ﬁve|ﬁve|NN independent|independent|JJ laboratories|laboratory|NNS .|.|. 
Introduction|introduction|NN *|*|NFP To|to|TO whom|whom|WP correspondence|correspondence|NN should|should|MD be|be|VB addressed|address|VBN .|.|. 
Tel|tel|NN :|:|: þ1|þ1|NN 860 441 3320|860 441 3320|NN ;|;|: Fax|fax|NN :|:|: þ1|þ1|NN 860 715 1251|860 715 1251|NN ;|;|: Email|email|NN :|:|: joel.i.ackerman@pﬁzer.com|joel.i.ackerman@pﬁzer.com|ADD The|the|DT Author|author|NN 2009|2009|CD .|.|. 
Published|publish|VBN by|by|IN Oxford|Oxford|NNP University|University|NNP Press|Press|NNP on|on|IN behalf|behalf|NN of|of|IN the|the|DT UK|UK|NNP Environmental|Environmental|NNP Mutagen|Mutagen|NNP Society|Society|NNP .|.|. 
All|all|DT rights|rights|NNS reserved|reserve|VBN .|.|. 
For|for|IN permissions|permission|NNS ,|,|, please|please|UH e-mail|e-mail|VB :|:|: journals.permissions@oxfordjournals.org|journals.permissions@oxfordjournals.org|ADD .|.|. 
433|433|CD Materials|material|NNS and|and|CC methods|method|NNS Test|test|VBP chemicals|chemical|NNS Ten|ten|CD model|model|NN compounds|compound|NNS were|be|VBD purchased|purchase|VBN (|(|-LRB- Sigma|Sigma|NNP ,|,|, St|St|NNP Louis|Louis|NNP ,|,|, MO|MO|NNP )|)|-RRB- and|and|CC used|use|VBN in|in|IN this|this|DT inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN :|:|: 2|2|CD -|-|HYPH amino|amino|NN -5-nitrophenol|-5-nitrophenol|NN (|(|-LRB- 2A5N|2a5n|NN )|)|-RRB- ,|,|, CAS|cas|NN #|#|NN 121|121|CD -88-0|-88-0|NN ;|;|: anthracene|anthracene|NN (|(|-LRB- Anthra|Anthra|NNP )|)|-RRB- ,|,|, CAS|cas|NN #|#|NN 120|120|CD -12-7|-12-7|NN ;|;|: benzyl|benzyl|NN chloride|chloride|NN (|(|-LRB- BC|bc|NN )|)|-RRB- ,|,|, CAS|CAS|NNP #|#|SYM 100|100|CD -44-7|-44-7|NN ;|;|: benzo|benzo|NN [|[|-LRB- a|a|DT ]|]|-RRB- pyrene|pyrene|NN (|(|-LRB- BaP|bap|NN )|)|-RRB- ,|,|, CAS|CAS|NNP #|#|SYM 50|50|CD -32-8|-32-8|NN ;|;|: 1,4|1,4|CD -|-|HYPH benzoquinone|benzoquinone|NN dioxime|dioxime|NN (|(|-LRB- 14BQD|14bqd|NN )|)|-RRB- ,|,|, CAS|CAS|NNP #|#|NN 105|105|CD -11-3|-11-3|NN ;|;|: 2|2|CD -|-|HYPH bromo|bromo|NN -|-|HYPH 4|4|CD ,6|,6|NN -|-|HYPH dinitroaniline|dinitroaniline|NN (|(|-LRB- 2B46dNA|2b46dna|NN )|)|-RRB- ,|,|, CAS|CAS|NNP #|#|NN 1817-73-8|1817-73-8|NN ;|;|: busulfan|busulfan|NN (|(|-LRB- Bus|bus|NN )|)|-RRB- ,|,|, CAS|cas|NN #|#|NN 55|55|CD -98-1|-98-1|NN ;|;|: crystal|crystal|NN violet|violet|NN (|(|-LRB- CV|cv|NN )|)|-RRB- ,|,|, CAS|cas|NN #|#|NN 548|548|CD -62-9|-62-9|NN ;|;|: 3|3|CD -|-|HYPH 3|3|CD #|#|SYM -|-|HYPH dimethoxybenzidine|dimethoxybenzidine|NN (|(|-LRB- 33DMB|33dmb|NN )|)|-RRB- ,|,|, CAS|cas|NN #|#|NN 119|119|CD -90-4|-90-4|NN and|and|CC nitrofurazone|nitrofurazone|NN (|(|-LRB- 5N2F|5n2f|NN )|)|-RRB- ,|,|, CAS|cas|NN #|#|NN 59|59|CD -87-0|-87-0|NN .|.|. 
Bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutation|mutation|NN assay|assay|NN Procedures|procedure|NNS were|be|VBD described|describe|VBN in|in|IN detail|detail|NN by|by|IN Aubrecht|Aubrecht|NNP et|et|FW al.|al.|FW (|(|-LRB- 18|18|CD )|)|-RRB- .|.|. 
Brieﬂy|Brieﬂy|NNP ,|,|, Salmonella|salmonella|NN cells|cell|NNS were|be|VBD grown|grow|VBN overnight|overnight|RB at|at|IN 37|37|CD C|c|NN ,|,|, under|under|IN shaking|shake|VBG (|(|-LRB- 250|250|CD r.p.m.|r.p.m.|NN )|)|-RRB- ,|,|, in|in|IN 35|35|CD ml|ml|NN of|of|IN Luria|Luria|NNP -|-|HYPH Bertani|Bertani|NNP (|(|-LRB- LB|LB|NNP )|)|-RRB- medium|medium|NN (|(|-LRB- Invitrogen|Invitrogen|NNP /|/|SYM Difco|Difco|NNP ,|,|, Grand|Grand|NNP Island|Island|NNP ,|,|, NY|NY|NNP )|)|-RRB- which|which|WDT was|be|VBD supplemented|supplement|VBN with|with|IN 50|50|CD lg|lg|NN /|/|SYM ml|ml|NN kanamycin|kanamycin|NN (|(|-LRB- Sigma|Sigma|NNP )|)|-RRB- .|.|. 
The|the|DT next|next|JJ morning|morning|NN ,|,|, the|the|DT culture|culture|NN was|be|VBD diluted|dilute|VBN 3:1|3:1|CD with|with|IN fresh|fresh|JJ LB|LB|NNP broth|broth|NN (|(|-LRB- with|with|IN supplemented|supplement|VBN kanamycin|kanamycin|NN )|)|-RRB- and|and|CC incubated|incubate|VBN at|at|IN 37|37|CD C|c|NN for|for|IN an|a|DT hour|hour|NN .|.|. 
Cells|cell|NNS were|be|VBD then|then|RB centrifuged|centrifuge|VBN and|and|CC washed|wash|VBN twice|twice|RB in|in|IN phosphate|phosphate|NN -|-|HYPH buffered|buffer|VBN saline|saline|NN (|(|-LRB- PBS|pbs|NN )|)|-RRB- (|(|-LRB- Sigma|Sigma|NNP )|)|-RRB- and|and|CC ﬁnally|ﬁnally|RB adjusted|adjust|VBN to|to|IN Optical|Optical|NNP Density|Density|NNP 660|660|CD 5|5|CD 0.5|0.5|CD in|in|IN the|the|DT ﬁnal|ﬁnal|JJ cell|cell|NN suspensions|suspension|NNS .|.|. 
For|for|IN sterile|sterile|JJ top|top|JJ agar|agar|NN solution|solution|NN of|of|IN 14.5|14.5|CD ml|ml|NN ,|,|, the|the|DT following|follow|VBG components|component|NNS were|be|VBD prepared|prepare|VBN :|:|: 400|400|CD ll|will|MD of|of|IN 50|50|CD Vogel|vogel|NN --|--|: Bonner|Bonner|NNP salt|salt|NN concentrate|concentrate|NN (|(|-LRB- Northeast|Northeast|NNP Laboratory|Laboratory|NNP ,|,|, Waterville|Waterville|NNP ,|,|, ME|ME|NNP )|)|-RRB- ,|,|, 880|880|CD ll|will|MD of|of|IN biotin|biotin|NN (|(|-LRB- 170|170|CD lg|lg|NN /|/|SYM ml|ml|NN )|)|-RRB- ,|,|, 20|20|CD ll|will|MD of|of|IN histidine|histidine|NN (|(|-LRB- 6.7|6.7|CD mg|mg|NN /|/|SYM ml|ml|NN )|)|-RRB- ,|,|, 20|20|CD ll|will|MD of|of|IN kanamycin|kanamycin|NN (|(|-LRB- 50|50|CD mg|mg|NNS /|/|SYM ml|ml|NN )|)|-RRB- ,|,|, 3.0|3.0|CD ml|ml|NN of|of|IN glucose|glucose|NN (|(|-LRB- 2.6|2.6|CD %|%|NN )|)|-RRB- ,|,|, 5.2|5.2|CD ml|ml|NN of|of|IN molten|molten|JJ agar|agar|NN (|(|-LRB- 2.4|2.4|CD %|%|NN )|)|-RRB- ,|,|, 5.0|5.0|CD ml|ml|NN of|of|IN ﬁnal|ﬁnal|JJ adjusted|adjust|VBN cells|cell|NNS (|(|-LRB- OD660|od660|NN 5|5|CD 0.5|0.5|CD )|)|-RRB- and|and|CC kept|keep|VBN at|at|IN 50|50|CD C.|C.|NNP To|to|TO minimize|minimize|VB the|the|DT exposure|exposure|NN of|of|IN Salmonella|salmonella|NN cells|cell|NNS to|to|IN a|a|DT high|high|JJ temperature|temperature|NN ,|,|, the|the|DT top|top|JJ agar|agar|NN mixture|mixture|NN was|be|VBD used|use|VBN within|within|IN 10|10|CD min|min|NN after|after|IN addition|addition|NN of|of|IN cell|cell|NN suspension|suspension|NN to|to|IN the|the|DT mix|mix|NN .|.|. 
The|the|DT assay|assay|NN was|be|VBD performed|perform|VBN in|in|IN 24|24|CD -|-|HYPH well|well|NN minimal|minimal|JJ agar|agar|NN plates|plate|NNS (|(|-LRB- 1|1|CD ml|ml|NN per|per|IN well|well|NN )|)|-RRB- prepared|prepared|JJ either|either|CC on|on|IN -|-|HYPH site|site|NN or|or|CC purchased|purchase|VBN (|(|-LRB- Molecular|Molecular|NNP Toxicology|Toxicology|NNP ,|,|, Boone|Boone|NNP ,|,|, NC|NC|NNP )|)|-RRB- .|.|. 
The|the|DT minimal|minimal|JJ agar|agar|NN was|be|VBD prepared|prepare|VBN using|use|VBG 15|15|CD g|g|NN Bacto|Bacto|NNP Agar|Agar|NNP (|(|-LRB- Difco|Difco|NNP ,|,|, Franklin|Franklin|NNP Lakes|Lakes|NNP ,|,|, NJ|NJ|NNP )|)|-RRB- ,|,|, 4|4|CD g|g|NN glucose|glucose|NN and|and|CC 20|20|CD ml|ml|NN of|of|IN 50|50|CD Vogel|vogel|NN --|--|: Bonner|Bonner|NNP salt|salt|NN concentrate|concentrate|NN (|(|-LRB- 1|1|CD %|%|NN MgSO4|mgso4|NN H|h|NN O|o|NN ,|,|, 10|10|CD %|%|NN citric|citric|JJ acid|acid|NN ,|,|, monohydrate|monohydrate|NN ,|,|, 50|50|CD %|%|NN K|k|NN HPO|hpo|NN ,|,|, 17.5|17.5|CD %|%|NN Na|na|NN NH|NH|NNP PO|po|NN 2|2|CD 2|2|CD 4|4|CD 2|2|CD 2|2|CD 4|4|CD 4H|4h|NN O|o|NN )|)|-RRB- in|in|IN total|total|JJ volume|volume|NN of|of|IN 1000|1000|CD ml|ml|NN of|of|IN distilled|distilled|JJ water|water|NN .|.|. 
Sterilized|sterilize|VBN agar|agar|NN was|be|VBD 2|2|CD tempered|temper|VBN to|to|IN 50|50|CD C|c|NN in|in|IN the|the|DT water|water|NN bath|bath|NN prior|prior|JJ dispensing|dispense|VBG 1|1|CD ml|ml|NN per|per|IN well|well|NN .|.|. 
The|the|DT assay|assay|NN procedure|procedure|NN was|be|VBD to|to|TO dispense|dispense|VB 17.5|17.5|CD ll|will|MD of|of|IN PBS|pbs|NN or|or|CC 17.5|17.5|CD ll|will|MD of|of|IN completed|complete|VBN S9|s9|NN mixture|mixture|NN of|of|IN Aroclor|Aroclor|NNP -|-|HYPH induced|induce|VBN rat|rat|NN S9|s9|NN liver|liver|NN homogenate|homogenate|NN onto|onto|IN the|the|DT well|well|NN per|per|IN agar|agar|NN .|.|. 
The|the|DT S9|s9|NN homogenate|homogenate|NN was|be|VBD purchased|purchase|VBN from|from|IN Molecular|Molecular|NNP Toxicology|Toxicology|NNP for|for|IN all|all|DT testing|testing|NN laboratories|laboratory|NNS except|except|IN Nagoya|Nagoya|NNP (|(|-LRB- NAG|NAG|NNP )|)|-RRB- ,|,|, which|which|WDT used|use|VBD S9|s9|NN from|from|IN Charles|Charles|NNP River|River|NNP (|(|-LRB- Wilmington|Wilmington|NNP ,|,|, MA|MA|NNP )|)|-RRB- .|.|. 
Then|then|RB ,|,|, either|either|CC 10|10|CD ll|will|MD of|of|IN the|the|DT compound|compound|NN solution|solution|NN or|or|CC negative|negative|JJ control|control|NN was|be|VBD added|add|VBN onto|onto|IN the|the|DT wells|well|NNS .|.|. 
Then|then|RB 72|72|CD ll|will|MD of|of|IN the|the|DT top|top|JJ agar|agar|NN containing|contain|VBG cells|cell|NNS was|be|VBD added|add|VBN .|.|. 
Each|each|DT 24|24|CD -|-|HYPH well|well|NN plate|plate|NN was|be|VBD agitated|agitate|VBN on|on|IN a|a|DT shaker|shaker|NN at|at|IN 950|950|CD r.p.m.|r.p.m.|NN to|to|TO allow|allow|VB even|even|RB distribution|distribution|NN of|of|IN cells|cell|NNS on|on|IN the|the|DT surface|surface|NN .|.|. 
The|the|DT range|range|NN of|of|IN ﬁnal|ﬁnal|JJ Salmonella|salmonella|NN cell|cell|NN density|density|NN was|be|VBD 4|4|CD 10|10|CD to|to|IN 3|3|CD 10|10|CD cells|cell|NNS per|per|IN well|well|NN over|over|IN the|the|DT ﬁve|ﬁve|NN laboratories|laboratory|NNS .|.|. 
The|the|DT 6|6|CD 7|7|CD standard|standard|NN doses|dose|NNS of|of|IN tested|test|VBN compounds|compound|NNS were|be|VBD 3-fold|3-fold|RB serial|serial|JJ dilutions|dilution|NNS starting|start|VBG at|at|IN 5|5|CD mg|mg|NNS per|per|IN well|well|NN or|or|CC plate|plate|NN .|.|. 
The|the|DT maximum|maximum|NN concentration|concentration|NN tested|test|VBN in|in|IN the|the|DT bioluminescent|bioluminescent|JJ assay|assay|NN was|be|VBD 1.35|1.35|CD mg|mg|NN /|/|SYM ml|ml|NN in|in|IN the|the|DT ﬁnal|ﬁnal|JJ overlay|overlay|NN ,|,|, which|which|WDT translates|translate|VBZ to|to|IN 0.135|0.135|CD mg|mg|NNS per|per|IN well|well|NN which|which|WDT corresponds|correspond|VBZ to|to|IN 5|5|CD mg|mg|NNS per|per|IN plate|plate|NN in|in|IN the|the|DT standard|standard|JJ Ames|Ames|NNP Salmonella|Salmonella|NNP assay|assay|NN .|.|. 
All|all|DT concentrations|concentration|NNS in|in|IN the|the|DT bioluminescent|bioluminescent|JJ assay|assay|NN were|be|VBD expressed|express|VBN as|as|IN corresponding|correspond|VBG milligrams|milligram|NNS per|per|IN plate|plate|NN equivalent|equivalent|NN to|to|TO facilitate|facilitate|VB the|the|DT comparison|comparison|NN of|of|IN Bioluminescent|bioluminescent|JJ and|and|CC plate|plate|NN assay|assay|NN data|datum|NNS .|.|. 
The|the|DT positive|positive|JJ controls|control|NNS for|for|IN TA100|ta100|NN -|-|HYPH lux|lux|NN and|and|CC TA98|ta98|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN were|be|VBD nitrofurantoin|nitrofurantoin|NN at|at|IN 0.007|0.007|CD mg|mg|NNS per|per|IN plate|plate|NN eq|eq|NN .|.|. 
and|and|CC 2|2|CD -|-|HYPH nitroﬂuorene|nitroﬂuorene|NN at|at|IN 0.018|0.018|CD mg|mg|NNS per|per|IN plate|plate|NN eq|eq|NN .|.|. 
,|,|, respectively|respectively|RB .|.|. 
The|the|DT positive|positive|JJ control|control|NN in|in|IN the|the|DT presence|presence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN for|for|IN strains|strain|NNS TA100|ta100|NN -|-|HYPH lux|lux|NN and|and|CC TA98|ta98|NN -|-|HYPH lux|lux|NN were|be|VBD 2|2|CD -|-|HYPH anthramine|anthramine|NN at|at|IN 0.018|0.018|CD mg|mg|NNS per|per|IN plate|plate|NN eq|eq|NN .|.|. 
and|and|CC 0.037|0.037|CD mg|mg|NNS per|per|IN plate|plate|NN eq|eq|NN .|.|. 
,|,|, respectively|respectively|RB .|.|. 
Plates|plate|NNS were|be|VBD incubated|incubate|VBN at|at|IN 37|37|CD C|c|NN for|for|IN 40|40|CD --|--|: 48|48|CD h|h|NN and|and|CC revertants|revertant|NNS of|of|IN luminescent|luminescent|JJ colonies|colony|NNS were|be|VBD captured|capture|VBN and|and|CC scored|score|VBN by|by|IN using|use|VBG photon|photon|NN counting|count|VBG CCD|ccd|NN camera|camera|NN (|(|-LRB- Lumi|Lumi|NNP -|-|HYPH Imager|Imager|NNP F1|f1|NN ,|,|, Roche|Roche|NNP ,|,|, Palo|Palo|NNP Alto|Alto|NNP ,|,|, CA|CA|NNP )|)|-RRB- .|.|. 
Inverted|invert|VBN images|image|NNS of|of|IN luminescent|luminescent|JJ revertants|revertant|NNS of|of|IN each|each|DT 24|24|CD -|-|HYPH well|well|NN per|per|IN each|each|DT plate|plate|NN were|be|VBD displayed|display|VBN .|.|. 
Numbers|number|NNS of|of|IN revertants|revertant|NNS in|in|IN negative|negative|JJ controls|control|NNS for|for|IN each|each|DT strain|strain|NN and|and|CC condition|condition|NN (|(|-LRB- i.e.|i.e.|FW direct|direct|JJ or|or|CC with|with|IN metabolic|metabolic|JJ activation|activation|NN )|)|-RRB- were|be|VBD pooled|pool|VBN to|to|TO obtain|obtain|VB daily|daily|JJ activity|activity|NN value|value|NN (|(|-LRB- DAC|dac|NN )|)|-RRB- .|.|. 
Averaged|average|VBN numbers|number|NNS of|of|IN revertants|revertant|NNS using|use|VBG doses|dose|NNS of|of|IN test|test|NN articles|article|NNS were|be|VBD compared|compare|VBN to|to|IN the|the|DT DAC|dac|NN for|for|IN respective|respective|JJ strain|strain|NN and|and|CC condition|condition|NN and|and|CC were|be|VBD reported|report|VBN as|as|IN fold|fold|JJ increases|increase|NNS .|.|. 
Inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN study|study|NN design|design|NN The|the|DT inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN involved|involve|VBN ﬁve|ﬁve|IN independent|independent|JJ laboratories|laboratory|NNS located|locate|VBN in|in|IN the|the|DT USA|USA|NNP [|[|-LRB- Groton|Groton|NNP (|(|-LRB- GTN|GTN|NNP )|)|-RRB- ,|,|, CT|ct|NN ;|;|: Cambridge|Cambridge|NNP (|(|-LRB- CAM|CAM|NNP )|)|-RRB- ,|,|, MA|MA|NNP and|and|CC La|La|NNP Jolla|Jolla|NNP (|(|-LRB- LJ|LJ|NNP )|)|-RRB- ,|,|, CA|CA|NNP ]|]|-RRB- ,|,|, Europe|Europe|NNP Sandwich|Sandwich|NNP (|(|-LRB- SDW|SDW|NNP )|)|-RRB- ,|,|, Kent|Kent|NNP ,|,|, UK|UK|NNP and|and|CC Asia|Asia|NNP Nagoya|Nagoya|NNP (|(|-LRB- NAG|NAG|NNP )|)|-RRB- Japan|Japan|NNP .|.|. 
The|the|DT compounds|compound|NNS were|be|VBD coded|code|VBN and|and|CC distributed|distribute|VBN from|from|IN our|we|PRP$ Groton|Groton|NNP laboratory|laboratory|NN in|in|IN a|a|DT blinded|blinded|JJ fashion|fashion|NN to|to|IN LJ|LJ|NNP ,|,|, CA|CA|NNP ;|;|: SDW|SDW|NNP ,|,|, UK|UK|NNP and|and|CC NAG|NAG|NNP ,|,|, Japan|Japan|NNP .|.|. 
The|the|DT laboratory|laboratory|NN located|locate|VBN in|in|IN CAM|CAM|NNP ,|,|, MA|MA|NNP purchased|purchase|VBD all|all|DT 10|10|CD compounds|compound|NNS independently|independently|RB from|from|IN the|the|DT same|same|JJ vendor|vendor|NN and|and|CC their|they|PRP$ studies|study|NNS were|be|VBD not|not|RB blinded|blind|VBN .|.|. 
All|all|DT 10|10|CD chemicals|chemical|NNS were|be|VBD tested|test|VBN in|in|IN at|at|IN least|least|RBS three|three|CD independent|independent|JJ experiments|experiment|NNS using|use|VBG strains|strain|NNS TA98|ta98|NN -|-|HYPH lux|lux|NN and|and|CC TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN and|and|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN (|(|-LRB- rat|rat|NN S9|s9|NN )|)|-RRB- .|.|. 
The|the|DT results|result|NNS were|be|VBD statistically|statistically|RB evaluated|evaluate|VBN using|use|VBG the|the|DT t|t|NN -|-|HYPH test|test|NN and|and|CC compared|compare|VBN to|to|IN each|each|DT site|site|NN and|and|CC to|to|IN published|publish|VBN NTP|ntp|NN results|result|NNS (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- .|.|. 
Evaluation|evaluation|NN criteria|criterion|NNS for|for|IN positive|positive|JJ responses|response|NNS of|of|IN the|the|DT ﬁve|ﬁve|NN inter-laboratory|inter-laboratory|JJ sites|site|NNS were|be|VBD dose|dose|NN dependent|dependent|JJ ,|,|, statistically|statistically|RB signiﬁcant|signiﬁcant|JJ (|(|-LRB- P|p|NN 0.05|0.05|CD )|)|-RRB- ,|,|, 2.0-fold|2.0-fold|RB increase|increase|NN of|of|IN revertant|revertant|NN colonies|colony|NNS over|over|IN negative|negative|JJ (|(|-LRB- untreated|untreated|JJ )|)|-RRB- controls|control|NNS .|.|. 
Evaluation|evaluation|NN criteria|criterion|NNS for|for|IN positive|positive|JJ responses|response|NNS of|of|IN NTP|NTP|NNP were|be|VBD 2.0-fold|2.0-fold|RB increase|increase|NN of|of|IN revertant|revertant|NN colonies|colony|NNS over|over|IN negative|negative|JJ (|(|-LRB- untreated|untreated|JJ )|)|-RRB- controls|control|NNS .|.|. 
All|all|DT data|datum|NNS were|be|VBD graphed|graph|VBN using|use|VBG GraphPad|GraphPad|NNP Prism|prism|NN 4|4|CD ,|,|, v.|v.|CC 4.00|4.00|CD (|(|-LRB- GraphPad|GraphPad|NNP Software|Software|NNP ,|,|, Inc.|Inc.|NNP ,|,|, San|San|NNP Diego|Diego|NNP ,|,|, CA|CA|NNP )|)|-RRB- .|.|. 
Results|result|NNS We|we|PRP have|have|VBP performed|perform|VBN an|a|DT inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN of|of|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN assay|assay|NN using|use|VBG 10|10|CD model|model|NN chemicals|chemical|NNS in|in|IN ﬁve|ﬁve|NN independent|independent|JJ laboratories|laboratory|NNS located|locate|VBN in|in|IN the|the|DT USA|USA|NNP :|:|: GTN|GTN|NNP ,|,|, CT|CT|NNP ,|,|, CAM|CAM|NNP ,|,|, Table|table|NN I.|I.|NNP Background|background|NN incidences|incidence|NNS of|of|IN revertants|revertant|NNS in|in|IN participating|participate|VBG laboratories|laboratory|NNS Strain|strain|NN /|/|SYM condition|condition|NN Site|site|NN a|a|DT GTN|gtn|NN SDW|sdw|NN LJ|lj|NN NAG|nag|NN CAM|cam|NN TA98|ta98|NN -|-|HYPH lux|lux|NN þ|þ|NN S9|s9|NN TA98|ta98|NN -|-|HYPH lux|lux|NN S9|s9|NN TA100|ta100|NN -|-|HYPH lux|lux|NN þ|þ|NN S9|s9|NN TA100|ta100|NN -|-|HYPH lux|lux|NN S9|s9|NN 1.50|1.50|CD b|b|NN 1.51|1.51|CD 5.85|5.85|CD 6.74|6.74|CD 1.50|1.50|CD b|b|SYM 1.55|1.55|CD 7.98|7.98|CD 7.73|7.73|CD 1.50|1.50|CD b|b|NN 1.51|1.51|CD 10.65|10.65|CD 12.25|12.25|CD 2.25|2.25|CD 1.96|1.96|CD 6.64|6.64|CD 5.20|5.20|CD 0.00|0.00|CD 0.03|0.03|CD 0.45|0.45|CD 0.89|0.89|CD 0.02|0.02|CD 0.06|0.06|CD 0.43|0.43|CD 0.67|0.67|CD 1.58|1.58|CD 1.57|1.57|CD 7.12|7.12|CD 7.64|7.64|CD 0.00|0.00|CD 0.06|0.06|CD 0.38|0.38|CD 0.64|0.64|CD 0.00|0.00|CD 0.03|0.03|CD 1.06|1.06|CD 1.07|1.07|CD 0.28|0.28|CD 0.38|0.38|CD 1.48|1.48|CD 1.28|1.28|CD SD|sd|NN for|for|IN individual|individual|JJ strains|strain|NNS and|and|CC conditions|condition|NNS .|.|. 
GTN|gtn|NN ,|,|, Individual|individual|JJ values|value|NNS represent|represent|VBP the|the|DT average|average|NN of|of|IN incidence|incidence|NN of|of|IN revertants|revertant|NNS in|in|IN solvent|solvent|JJ treated|treat|VBN wells|well|NNS (|(|-LRB- negative|negative|JJ controls|control|NNS )|)|-RRB- Groton|Groton|NNP CT|CT|NNP ;|;|: SDW|SDW|NNP ,|,|, Sandwich|Sandwich|NNP ,|,|, Kent|Kent|NNP ,|,|, UK|UK|NNP ;|;|: LJ|LJ|NNP ,|,|, La|La|NNP Jolla|Jolla|NNP CA|CA|NNP ;|;|: NAG|NAG|NNP ,|,|, Nagoya|Nagoya|NNP ,|,|, Japan|Japan|NNP ;|;|: CAM|CAM|NNP ,|,|, Cambridge|Cambridge|NNP ,|,|, MA|MA|NNP .|.|. 
a|a|DT TA98|ta98|NN -|-|HYPH lux|lux|NN and|and|CC TA100|ta100|NN -|-|HYPH lux|lux|NN strains|strain|NNS ,|,|, tested|test|VBN directly|directly|RB (|(|-LRB- without|without|IN rat|rat|NN S9|s9|NN )|)|-RRB- or|or|CC with|with|IN metabolic|metabolic|JJ activation|activation|NN (|(|-LRB- plus|plus|CC S9|s9|NN )|)|-RRB- .|.|. 
b|b|LS Represents|Represents|NNPS default|default|NN value|value|NN for|for|IN background|background|NN incidence|incidence|NN of|of|IN revertants|revertant|NNS in|in|IN untreated|untreated|JJ wells|well|NNS with|with|IN TA98|ta98|NN -|-|HYPH lux|lux|NN strain|strain|NN .|.|. 
Table|table|NN II|ii|CD .|.|. 
Increases|increase|VBZ in|in|IN revertants|revertant|NNS counts|count|NNS after|after|IN treatment|treatment|NN with|with|IN positive|positive|JJ control|control|NN compounds|compound|NNS Positive|positive|JJ controls|control|NNS Site|Site|NNP GTN|GTN|NNP SDW|SDW|NNP LJ|LJ|NNP NAG|NAG|NNP CAM|CAM|NNP TA98|ta98|NN -|-|HYPH lux|lux|NN þ|þ|NN S9|s9|NN :|:|: 2|2|CD -|-|HYPH A|a|DT TA98|ta98|NN -|-|HYPH lux|lux|NN S9|s9|NN :|:|: 2|2|CD -|-|HYPH Nit|nit|NN TA100|ta100|NN -|-|HYPH lux|lux|NN þ|þ|NN S9|s9|NN :|:|: 2|2|CD -|-|HYPH A|a|DT TA100|ta100|NN -|-|HYPH lux|lux|NN S9|s9|NN :|:|: Nit|Nit|NNP 5.0|5.0|CD 4.2|4.2|CD 1.5|1.5|CD 1.7|1.7|CD 38.2|38.2|CD 23.9|23.9|CD 9.5|9.5|CD 8.2|8.2|CD 12.2|12.2|CD 4.7|4.7|CD 3.4|3.4|CD 2.1|2.1|CD 34.1|34.1|CD 17.9|17.9|CD 13.1|13.1|CD 6.7|6.7|CD 5.2|5.2|CD 4.1|4.1|CD 1.4|1.4|CD 1.8|1.8|CD 32.0|32.0|CD 24.2|24.2|CD 9.8|9.8|CD 3.3|3.3|CD 3.8|3.8|CD 5.2|5.2|CD 2.0|2.0|CD 1.3|1.3|CD 42.0|42.0|CD 31.2|31.2|CD 7.3|7.3|CD 5.4|5.4|CD 11.1|11.1|CD 9.6|9.6|CD 2.6|2.6|CD 1.8|1.8|CD 34.2|34.2|CD 31.6|31.6|CD 7.1|7.1|CD 5.0|5.0|CD Individual|individual|JJ values|value|NNS represent|represent|VBP average|average|JJ fold|fold|RB of|of|IN increase|increase|NN of|of|IN revertants|revertant|NNS in|in|IN wells|well|NNS treated|treat|VBN with|with|IN positive|positive|JJ reference|reference|NN compounds|compound|NNS (|(|-LRB- positive|positive|JJ control|control|NN )|)|-RRB- .|.|. 
GTN|gtn|NN ,|,|, Groton|Groton|NNP CT|CT|NNP ;|;|: SDW|SDW|NNP ,|,|, Sandwich|Sandwich|NNP ,|,|, Kent|Kent|NNP ,|,|, UK|UK|NNP ;|;|: LJ|LJ|NNP ,|,|, La|La|NNP Jolla|Jolla|NNP CA|CA|NNP ;|;|: NAG|NAG|NNP ,|,|, Nagoya|Nagoya|NNP ,|,|, Japan|Japan|NNP ;|;|: CAM|CAM|NNP ,|,|, Cambridge|Cambridge|NNP ,|,|, MA|MA|NNP .|.|. 
2|2|CD -|-|HYPH A|a|NN ,|,|, 2|2|CD -|-|HYPH anthramine|anthramine|NN ;|;|: 2|2|CD -|-|HYPH Nit|nit|NN ,|,|, 2|2|CD -|-|HYPH nitroﬂuorene|nitroﬂuorene|NN ;|;|: Nit|nit|NN ,|,|, nitrofurantoin|nitrofurantoin|NN .|.|. 
MA|MA|NNP and|and|CC LJ|LJ|NNP ,|,|, CA|CA|NNP ;|;|: Europe|Europe|NNP :|:|: SDW|SDW|NNP ,|,|, Kent|Kent|NNP ,|,|, UK|UK|NNP and|and|CC Asia|Asia|NNP :|:|: NAG|NAG|NNP ,|,|, Japan|Japan|NNP .|.|. 
The|the|DT studies|study|NNS were|be|VBD performed|perform|VBN in|in|IN blinded|blinded|JJ fashion|fashion|NN at|at|IN all|all|DT laboratories|laboratory|NNS except|except|IN for|for|IN GTN|gtn|NN and|and|CC CAM|cam|NN .|.|. 
The|the|DT chemicals|chemical|NNS were|be|VBD tested|test|VBN in|in|IN at|at|IN least|least|RBS three|three|CD independent|independent|JJ experiments|experiment|NNS using|use|VBG strains|strain|NNS TA98|ta98|NN -|-|HYPH lux|lux|NN and|and|CC TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN and|and|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN (|(|-LRB- rat|rat|NN S9|s9|NN )|)|-RRB- .|.|. 
The|the|DT results|result|NNS were|be|VBD statistically|statistically|RB evaluated|evaluate|VBN according|accord|VBG to|to|IN the|the|DT criteria|criterion|NNS described|describe|VBN in|in|IN Materials|material|NNS and|and|CC Methods|method|NNS and|and|CC compared|compare|VBN to|to|IN previously|previously|RB published|publish|VBN Salmonella|Salmonella|NNP assay|assay|NN results|result|NNS (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- .|.|. 
The|the|DT range|range|NN of|of|IN average|average|JJ background|background|NN incidences|incidence|NNS of|of|IN revertants|revertant|NNS is|be|VBZ presented|present|VBN in|in|IN Table|table|NN I|I|PRP .|.|. 
In|in|IN case|case|NN of|of|IN TA100|ta100|NN -|-|HYPH lux|lux|NN strain|strain|NN in|in|IN the|the|DT presence|presence|NN or|or|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN ,|,|, the|the|DT background|background|NN ranged|range|VBD from|from|IN 5.2|5.2|CD to|to|IN 12.3|12.3|CD revertants|revertant|NNS per|per|IN well|well|NN across|across|IN individual|individual|JJ laboratories|laboratory|NNS .|.|. 
The|the|DT average|average|JJ background|background|NN incidence|incidence|NN of|of|IN revertants|revertant|NNS for|for|IN TA98|ta98|NN -|-|HYPH lux|lux|NN strain|strain|NN in|in|IN the|the|DT presence|presence|NN or|or|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN ranged|range|VBD from|from|IN 0.5|0.5|CD to|to|IN 2.3|2.3|CD .|.|. 
Due|due|IN to|to|IN low|low|JJ background|background|NN incidence|incidence|NN of|of|IN revertant|revertant|NN colonies|colony|NNS in|in|IN the|the|DT TA98|ta98|NN -|-|HYPH lux|lux|NN strain|strain|NN ,|,|, we|we|PRP have|have|VBP used|use|VBN a|a|DT default|default|NN 1.5|1.5|CD revertants|revertant|NNS per|per|IN well|well|NN as|as|IN the|the|DT background|background|NN for|for|IN experiments|experiment|NNS that|that|WDT yielded|yield|VBD ,1.5|,1.5|NN revertants|revertant|NNS per|per|IN well|well|NN .|.|. 
The|the|DT results|result|NNS in|in|IN individual|individual|JJ laboratories|laboratory|NNS with|with|IN positive|positive|JJ control|control|NN compounds|compound|NNS are|be|VBP summarized|summarize|VBN in|in|IN Table|table|NN II|ii|CD .|.|. 
The|the|DT treatment|treatment|NN of|of|IN TA98|ta98|NN -|-|HYPH lux|lux|NN cells|cell|NNS with|with|IN 2|2|CD -|-|HYPH anthramine|anthramine|NN in|in|IN the|the|DT presence|presence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN or|or|CC 2|2|CD -|-|HYPH nitroﬂuorene|nitroﬂuorene|NN in|in|IN absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN resulted|result|VBD in|in|IN 32.0|32.0|CD -|-|HYPH to|to|IN 42.0-fold|42.0-fold|JJ or|or|CC 17.9|17.9|CD -|-|HYPH to|to|IN 31.6-fold|31.6-fold|JJ increase|increase|NN of|of|IN revertant|revertant|NN colonies|colony|NNS ,|,|, respectively|respectively|RB .|.|. 
In|in|IN case|case|NN of|of|IN TA100|ta100|NN -|-|HYPH lux|lux|NN ,|,|, the|the|DT treatment|treatment|NN with|with|IN 2|2|CD -|-|HYPH anthramine|anthramine|NN in|in|IN the|the|DT presence|presence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN and|and|CC nitrofurantoin|nitrofurantoin|NN in|in|IN absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN resulted|result|VBD in|in|IN 7.1|7.1|CD -|-|HYPH to|to|IN 13.1-fold|13.1-fold|JJ increase|increase|NN or|or|CC 3.3|3.3|CD -|-|HYPH to|to|IN 8.2-fold|8.2-fold|RB induction|induction|NN of|of|IN revertants|revertant|NNS ,|,|, respectively|respectively|RB .|.|. 
The|the|DT results|result|NNS of|of|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN assay|assay|NN and|and|CC previously|previously|RB published|publish|VBN data|datum|NNS for|for|IN all|all|DT 10|10|CD model|model|NN compounds|compound|NNS are|be|VBP summarized|summarize|VBN in|in|IN Table|table|NN III|iii|CD .|.|. 
Considering|consider|VBG results|result|NNS from|from|IN both|both|DT testing|testing|NN conditions|condition|NNS (|(|-LRB- presence|presence|NN and|and|CC absence|absence|NN of|of|IN S9|s9|NN )|)|-RRB- together|together|RB ,|,|, there|there|EX was|be|VBD 100|100|CD %|%|NN concordance|concordance|NN (|(|-LRB- 10|10|CD of|of|IN 10|10|CD )|)|-RRB- among|among|IN the|the|DT ﬁve|ﬁve|NN laboratories|laboratory|NNS and|and|CC the|the|DT previously|previously|RB published|publish|VBN results|result|NNS by|by|IN NTP|NTP|NNP (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- .|.|. 
Seven|seven|CD of|of|IN the|the|DT 10|10|CD compounds|compound|NNS tested|test|VBN were|be|VBD positive|positive|JJ either|either|CC in|in|IN the|the|DT TA98|ta98|NN -|-|HYPH lux|lux|NN and|and|CC /|/|HYPH or|or|CC TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN or|or|CC absence|absence|NN of|of|IN S9|s9|NN at|at|IN all|all|DT ﬁve|ﬁve|NN laboratories|laboratory|NNS .|.|. 
This|this|DT compound|compound|NN set|set|NN included|include|VBD :|:|: 5N2F|5n2f|NN ,|,|, 33DMB|33dmb|NN ,|,|, BaP|bap|NN ,|,|, 14BQD|14bqd|NN ,|,|, 2A5N|2a5n|NN ,|,|, 2B46dNA|2b46dna|NN and|and|CC Bus|bus|NN .|.|. 
Three|three|CD compounds|compound|NNS reported|report|VBD negative|negative|JJ in|in|IN the|the|DT literature|literature|NN with|with|IN TA98|ta98|NN and|and|CC TA100|ta100|NN were|be|VBD found|find|VBN non-mutagenic|non-mutagenic|JJ at|at|IN all|all|DT ﬁve|ﬁve|NN laboratories|laboratory|NNS when|when|WRB tested|test|VBN using|use|VBG both|both|DT TA98|ta98|NN -|-|HYPH lux|lux|NN and|and|CC TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN or|or|CC absence|absence|NN of|of|IN S9|s9|NN .|.|. 
Negative|negative|JJ compounds|compound|NNS were|be|VBD Anthra|Anthra|NNP ,|,|, CV|CV|NNP and|and|CC BC|BC|NNP .|.|. 
The|the|DT detailed|detailed|JJ comparison|comparison|NN of|of|IN individual|individual|JJ bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN assay|assay|NN results|result|VBZ from|from|IN participating|participate|VBG laboratories|laboratory|NNS (|(|-LRB- strain|strain|NN in|in|IN the|the|DT absence|absence|NN or|or|CC presence|presence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN )|)|-RRB- with|with|IN previously|previously|RB published|publish|VBN data|datum|NNS (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- revealed|reveal|VBD 87.5|87.5|CD %|%|NN concordant|concordant|JJ results|result|NNS (|(|-LRB- 35|35|CD of|of|IN 40|40|CD )|)|-RRB- .|.|. 
Although|although|IN the|the|DT 33DMB|33dmb|NN was|be|VBD positive|positive|JJ in|in|IN a|a|DT previously|previously|RB published|publish|VBN study|study|NN with|with|IN TA98|ta98|NN and|and|CC ,|,|, also|also|RB ,|,|, in|in|IN all|all|DT participating|participate|VBG laboratories|laboratory|NNS with|with|IN TA98|ta98|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN of|of|IN S9|s9|NN ,|,|, the|the|DT compound|compound|NN was|be|VBD also|also|RB reported|report|VBN positive|positive|JJ in|in|IN TA98|ta98|NN in|in|IN absence|absence|NN of|of|IN S9|s9|NN and|and|CC TA100|ta100|NN in|in|IN the|the|DT presence|presence|NN of|of|IN S9|s9|NN .|.|. 
Only|only|RB the|the|DT Nagoya|Nagoya|NNP laboratory|laboratory|NN (|(|-LRB- NAG|nag|NN )|)|-RRB- tested|test|VBN 33DMB|33dmb|NN as|as|IN positive|positive|JJ in|in|IN TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN of|of|IN S9|s9|NN .|.|. 
In|in|IN the|the|DT case|case|NN of|of|IN 2B46dNA|2b46dna|NN ,|,|, there|there|EX was|be|VBD an|a|DT agreement|agreement|NN among|among|IN published|publish|VBN data|datum|NNS with|with|IN TA98|ta98|NN and|and|CC all|all|DT participating|participate|VBG laboratories|laboratory|NNS with|with|IN TA98|ta98|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN and|and|CC absence|absence|NN of|of|IN S9|s9|NN .|.|. 
On|on|IN the|the|DT other|other|JJ hand|hand|NN ,|,|, the|the|DT reported|report|VBN positive|positive|JJ data|datum|NNS for|for|IN 2B46dNA|2b46dna|NN in|in|IN TA100|ta100|NN in|in|IN the|the|DT presence|presence|NN and|and|CC absence|absence|NN of|of|IN S9|s9|NN were|be|VBD conﬁrmed|conﬁrmed|VBN with|with|IN TA100|ta100|NN -|-|HYPH lux|lux|NN strain|strain|NN only|only|RB in|in|IN three|three|CD out|out|IN of|of|IN ﬁve|ﬁve|NN laboratories|laboratory|NNS .|.|. 
In|in|IN the|the|DT case|case|NN of|of|IN 14BQD|14bqd|NN ,|,|, there|there|EX was|be|VBD complete|complete|JJ agreement|agreement|NN between|between|IN published|publish|VBN TA98|ta98|NN results|result|NNS and|and|CC data|datum|NNS obtained|obtain|VBN in|in|IN all|all|DT participating|participate|VBG laboratories|laboratory|NNS with|with|IN TA98|ta98|NN -|-|HYPH lux|lux|NN in|in|IN both|both|CC the|the|DT presence|presence|NN and|and|CC absence|absence|NN of|of|IN S9|s9|NN .|.|. 
However|however|RB ,|,|, the|the|DT reported|report|VBN positive|positive|JJ result|result|NN in|in|IN TA100|ta100|NN in|in|IN the|the|DT absence|absence|NN Table|table|NN III|iii|CD .|.|. 
Inter-laboratory|inter-laboratory|JJ evaluations|evaluation|NNS of|of|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutation|mutation|NN assay|assay|NN compared|compare|VBN to|to|IN the|the|DT NTP|NTP|NNP for|for|IN 10|10|CD model|model|NN chemicals|chemical|NNS NTP|NTP|NNP GTN|GTN|NNP NAG|NAG|NNP LJ|LJ|NNP SDW|SDW|NNP CAM|CAM|NNP Anthra|Anthra|NNP 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD 5N2F|5n2f|NN 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD 33DMB|33dmb|NN 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD BaP|bap|NN 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 98|98|CD 14BQD|14bqd|CD 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD 2A5N|2a5n|NN 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD 2B46dNA|2b46dna|NN 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD BC|bc|NN 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD CV|cv|NN 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD Bus|Bus|NNP 98þ|98þ|CD 98|98|CD 100þ|100þ|CD 100|100|CD þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW Sites|Sites|NNPS :|:|: Participating|participate|VBG laboratories|laboratory|NNS :|:|: GTN|gtn|NN ,|,|, Groton|Groton|NNP CT|CT|NNP ;|;|: SDW|SDW|NNP ,|,|, Sandwich|Sandwich|NNP ,|,|, Kent|Kent|NNP ,|,|, UK|UK|NNP ;|;|: LJ|LJ|NNP ,|,|, La|La|NNP Jolla|Jolla|NNP CA|CA|NNP ;|;|: NAG|NAG|NNP ,|,|, Nagoya|Nagoya|NNP ,|,|, Japan|Japan|NNP ;|;|: CAM|CAM|NNP ,|,|, Cambridge|Cambridge|NNP ,|,|, MA|MA|NNP .|.|. 
NTP|ntp|NN represent|represent|VBP data|datum|NNS from|from|IN National|National|NNP Toxicology|Toxicology|NNP Program|Program|NNP (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- .|.|. 
Evaluation|evaluation|NN criteria|criterion|NNS for|for|IN positive|positive|JJ responses|response|NNS in|in|IN sites|site|NNS :|:|: dose|dose|NN dependent|dependent|JJ ,|,|, statistically|statistically|RB signiﬁcant|signiﬁcant|JJ (|(|-LRB- P|p|NN 0.05|0.05|CD )|)|-RRB- ,|,|, 2.0-fold|2.0-fold|RB increase|increase|NN of|of|IN revertant|revertant|NN colonies|colony|NNS over|over|IN untreated|untreated|JJ (|(|-LRB- negative|negative|JJ )|)|-RRB- controls|control|NNS .|.|. 
Evaluation|evaluation|NN criteria|criterion|NNS for|for|IN positive|positive|JJ responses|response|NNS in|in|IN NTP|NTP|NNP :|:|: average|average|NN of|of|IN 2.0|2.0|CD -|-|HYPH fold|fold|NN -|-|HYPH increase|increase|NN of|of|IN revertant|revertant|NN colonies|colony|NNS over|over|IN untreated|untreated|JJ (|(|-LRB- negative|negative|JJ )|)|-RRB- controls|control|VBZ utilizing|utilize|VBG 1|1|CD -|-|HYPH 3|3|CD contract|contract|NN labs|lab|NNS .|.|. 
of|of|IN S9|s9|NN was|be|VBD not|not|RB reproduced|reproduce|VBN in|in|IN TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN any|any|DT of|of|IN the|the|DT participating|participate|VBG laboratories|laboratory|NNS .|.|. 
The|the|DT individual|individual|JJ responses|response|NNS to|to|IN treatment|treatment|NN with|with|IN model|model|NN compounds|compound|NNS (|(|-LRB- strain|strain|NN in|in|IN the|the|DT absence|absence|NN or|or|CC presence|presence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN )|)|-RRB- were|be|VBD consistent|consistent|JJ across|across|IN participating|participate|VBG laboratories|laboratory|NNS providing|provide|VBG 92.5|92.5|CD %|%|NN concordant|concordant|JJ results|result|NNS (|(|-LRB- 37|37|CD of|of|IN 40|40|CD )|)|-RRB- .|.|. 
The|the|DT negative|negative|JJ compounds|compound|NNS (|(|-LRB- Anthra|Anthra|NNP ,|,|, BC|BC|NNP and|and|CC CV|CV|NNP )|)|-RRB- did|do|VBD not|not|RB increase|increase|VB the|the|DT incidence|incidence|NN of|of|IN revertants|revertant|NNS at|at|IN any|any|DT of|of|IN the|the|DT tested|test|VBN concentrations|concentration|NNS (|(|-LRB- Figure|figure|NN 1|1|CD )|)|-RRB- .|.|. 
Nitrofurazone|Nitrofurazone|NNP was|be|VBD positive|positive|JJ with|with|IN all|all|DT four|four|CD test|test|NN conditions|condition|NNS at|at|IN all|all|DT participating|participate|VBG laboratories|laboratory|NNS producing|produce|VBG a|a|DT characteristic|characteristic|JJ bell|bell|NN shape|shape|NN dose|dose|NN --|--|: response|response|NN curve|curve|NN (|(|-LRB- Figure|figure|NN 2A|2a|NN )|)|-RRB- .|.|. 
Consisted|consist|VBN with|with|IN expectations|expectation|NNS ,|,|, BaP|bap|NN was|be|VBD positive|positive|JJ only|only|RB with|with|IN metabolic|metabolic|JJ activation|activation|NN in|in|IN both|both|CC strains|strain|NNS TA100|ta100|NN -|-|HYPH lux|lux|NN and|and|CC TA98|ta98|NN -|-|HYPH lux|lux|NN (|(|-LRB- Figure|figure|NN 2B|2b|NN )|)|-RRB- .|.|. 
Furthermore|furthermore|RB ,|,|, 1,4|1,4|CD -|-|HYPH benzoquinone|benzoquinone|NN and|and|CC 2A5N|2a5n|NN (|(|-LRB- Figure|figure|NN 2C|2c|NN and|and|CC 2D|2d|NN ,|,|, respectively|respectively|RB )|)|-RRB- were|be|VBD positive|positive|JJ only|only|RB with|with|IN TA98|ta98|NN -|-|HYPH lux|lux|NN both|both|CC direct|direct|JJ and|and|CC with|with|IN metabolic|metabolic|JJ activation|activation|NN and|and|CC Bus|bus|NN (|(|-LRB- Figure|figure|NN 2E|2e|NN )|)|-RRB- was|be|VBD positive|positive|JJ only|only|RB with|with|IN TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN and|and|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN .|.|. 
In|in|IN case|case|NN of|of|IN the|the|DT compounds|compound|NNS with|with|IN discordant|discordant|JJ results|result|NNS among|among|IN the|the|DT participating|participate|VBG laboratories|laboratory|NNS ,|,|, 33DMB|33dmb|NN with|with|IN TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN of|of|IN S9|s9|NN produced|produce|VBD a|a|DT weak|weak|JJ positive|positive|JJ response|response|NN (|(|-LRB- ,2.5|,2.5|NN )|)|-RRB- only|only|RB at|at|IN NAG|NAG|NNP laboratory|laboratory|NN (|(|-LRB- Figure|figure|NN 3A|3a|NN )|)|-RRB- .|.|. 
Furthermore|furthermore|RB ,|,|, 2B46dNA|2b46dna|NN yielded|yield|VBD a|a|DT weak|weak|JJ positive|positive|JJ response|response|NN with|with|IN TA100|ta100|NN in|in|IN the|the|DT presence|presence|NN of|of|IN S9|s9|NN at|at|IN NAG|NAG|NNP ,|,|, LJ|LJ|NNP and|and|CC CAM|CAM|NNP and|and|CC only|only|RB one|one|CD laboratory|laboratory|NN (|(|-LRB- NAG|nag|NN )|)|-RRB- had|have|VBD a|a|DT weak|weak|JJ positive|positive|JJ response|response|NN with|with|IN TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN absence|absence|NN of|of|IN S9|s9|NN (|(|-LRB- Figure|figure|NN 3B|3b|NN )|)|-RRB- .|.|. 
þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW þ|þ|FW Discussion|discussion|NN Previously|previously|RB ,|,|, we|we|PRP have|have|VBP reported|report|VBN the|the|DT development|development|NN of|of|IN the|the|DT higher|higher|JJR throughput|throughput|NN bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutation|mutation|NN assay|assay|NN as|as|IN a|a|DT screening|screening|NN tool|tool|NN that|that|WDT could|could|MD be|be|VB applied|apply|VBN for|for|IN the|the|DT prioritization|prioritization|NN of|of|IN the|the|DT compounds|compound|NNS in|in|IN pharmaceutical|pharmaceutical|JJ drug|drug|NN discovery|discovery|NN (|(|-LRB- 18|18|CD )|)|-RRB- .|.|. 
We|we|PRP have|have|VBP reported|report|VBN a|a|DT 93|93|CD --|--|: 95|95|CD %|%|NN concordance|concordance|NN of|of|IN 105|105|CD model|model|NN compounds|compound|NNS between|between|IN the|the|DT bioluminescent|bioluminescent|JJ assay|assay|NN and|and|CC previously|previously|RB published|publish|VBN data|datum|NNS utilizing|utilize|VBG the|the|DT standard|standard|JJ Ames|Ames|NNP assay|assay|NN (|(|-LRB- 18|18|CD )|)|-RRB- .|.|. 
Here|here|RB ,|,|, we|we|PRP set|set|VBD out|out|RP to|to|TO evaluate|evaluate|VB the|the|DT robustness|robustness|NN ,|,|, reproducibility|reproducibility|NN and|and|CC accuracy|accuracy|NN of|of|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN assay|assay|NN via|via|IN inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN study|study|NN .|.|. 
A|a|DT total|total|NN of|of|IN ﬁve|ﬁve|NN independent|independent|JJ laboratories|laboratory|NNS located|locate|VBN on|on|IN three|three|CD continents|continent|NNS participated|participate|VBD in|in|IN the|the|DT study|study|NN .|.|. 
To|to|TO allow|allow|VB for|for|IN the|the|DT gaining|gain|VBG of|of|IN experience|experience|NN of|of|IN participating|participate|VBG laboratories|laboratory|NNS with|with|IN the|the|DT assay|assay|NN ,|,|, the|the|DT inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN study|study|NN reported|report|VBN here|here|RB was|be|VBD done|do|VBN 12|12|CD months|month|NNS or|or|CC later|later|RB after|after|IN assay|assay|NN implementation|implementation|NN on|on|IN individual|individual|JJ locations|location|NNS .|.|. 
To|to|TO mimic|mimic|VB a|a|DT `|`|`` real|real|JJ -|-|HYPH life|life|NN '|'|'' screening|screening|NN application|application|NN ,|,|, the|the|DT test|test|NN set|set|NN of|of|IN 10|10|CD model|model|NN compounds|compound|NNS was|be|VBD evaluated|evaluate|VBN in|in|IN a|a|DT sub-set|sub-set|NN of|of|IN laboratories|laboratory|NNS in|in|IN a|a|DT blinded|blinded|JJ fashion|fashion|NN .|.|. 
We|we|PRP selected|select|VBD 10|10|CD model|model|NN compounds|compound|NNS with|with|IN a|a|DT range|range|NN of|of|IN mutagenic|mutagenic|JJ activities|activity|NNS .|.|. 
Seven|seven|CD compounds|compound|NNS were|be|VBD positive|positive|JJ in|in|IN either|either|CC ,|,|, or|or|CC both|both|DT strains|strain|NNS ,|,|, and|and|CC test|test|NN conditions|condition|NNS and|and|CC three|three|CD compounds|compound|NNS were|be|VBD negative|negative|JJ .|.|. 
In|in|IN addition|addition|NN to|to|IN evaluating|evaluate|VBG the|the|DT reproducibility|reproducibility|NN of|of|IN the|the|DT data|datum|NNS among|among|IN the|the|DT participating|participate|VBG laboratories|laboratory|NNS ,|,|, the|the|DT results|result|NNS were|be|VBD also|also|RB compared|compare|VBN with|with|IN previously|previously|RB published|publish|VBN data|datum|NNS (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- .|.|. 
The|the|DT average|average|JJ background|background|NN incidence|incidence|NN of|of|IN revertants|revertant|NNS for|for|IN the|the|DT TA100|ta100|NN -|-|HYPH lux|lux|NN strain|strain|NN in|in|IN the|the|DT presence|presence|NN or|or|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN across|across|IN individual|individual|JJ laboratories|laboratory|NNS held|hold|VBD steady|steady|JJ in|in|IN the|the|DT range|range|NN of|of|IN 5.2|5.2|CD --|--|: 12.3|12.3|CD revertants|revertant|NNS per|per|IN well|well|NN .|.|. 
In|in|IN the|the|DT case|case|NN of|of|IN TA98|ta98|NN -|-|HYPH lux|lux|NN ,|,|, the|the|DT background|background|NN incidence|incidence|NN of|of|IN revertants|revertant|NNS for|for|IN the|the|DT TA98|ta98|NN -|-|HYPH lux|lux|NN strain|strain|NN in|in|IN the|the|DT presence|presence|NN or|or|CC absence|absence|NN of|of|IN metabolic|metabolic|JJ activation|activation|NN across|across|IN laboratories|laboratory|NNS ranged|range|VBD from|from|IN 1.5|1.5|CD to|to|IN 2.3|2.3|CD .|.|. 
The|the|DT fact|fact|NN that|that|IN the|the|DT previously|previously|RB published|publish|VBN background|background|NN (|(|-LRB- 18|18|CD )|)|-RRB- for|for|IN strains|strain|NNS TA100|ta100|NN -|-|HYPH lux|lux|NN and|and|CC TA98|ta98|NN -|-|HYPH lux|lux|NN was|be|VBD 10.1|10.1|CD 2.3|2.3|CD and|and|CC 2.1|2.1|CD 1.2|1.2|CD ,|,|, respectively|respectively|RB ,|,|, indicates|indicate|VBZ the|the|DT stability|stability|NN of|of|IN our|we|PRP$ bioluminescent|bioluminescent|JJ strains|strain|NNS .|.|. 
Since|since|IN the|the|DT variation|variation|NN in|in|IN the|the|DT background|background|NN frequency|frequency|NN within|within|IN each|each|DT individual|individual|JJ laboratory|laboratory|NN was|be|VBD a|a|DT relatively|relatively|RB small|small|JJ range|range|NN (|(|-LRB- two|two|CD to|to|IN three|three|CD revertants|revertant|NNS per|per|IN well|well|NN )|)|-RRB- ,|,|, the|the|DT background|background|NN frequency|frequency|NN likely|likely|JJ reﬂects|reﬂects|NNS differences|difference|NNS in|in|IN cell|cell|NN numbers|number|NNS plated|plate|VBN .|.|. 
Although|although|IN the|the|DT background|background|NN frequency|frequency|NN does|do|VBZ not|not|RB seem|seem|VB to|to|TO inﬂuence|inﬂuence|VB the|the|DT overall|overall|JJ interpretation|interpretation|NN of|of|IN the|the|DT data|datum|NNS ,|,|, it|it|PRP is|be|VBZ likely|likely|JJ that|that|IN the|the|DT low|low|JJ background|background|NN contributed|contribute|VBD to|to|IN the|the|DT weak|weak|JJ positive|positive|JJ result|result|NN for|for|IN 33DMB|33dmb|NN with|with|IN TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT presence|presence|NN of|of|IN S9|s9|NN seen|see|VBN in|in|IN the|the|DT NAG|NAG|NNP laboratory|laboratory|NN where|where|WRB the|the|DT negative|negative|JJ background|background|NN by|by|IN the|the|DT NTP|NTP|NNP (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- in|in|IN the|the|DT identiﬁcation|identiﬁcation|NN of|of|IN mutagenic|mutagenic|JJ compounds|compound|NNS .|.|. 
Seven|seven|CD compounds|compound|NNS were|be|VBD mutagenic|mutagenic|JJ and|and|CC the|the|DT other|other|JJ three|three|CD were|be|VBD non-mutagenic|non-mutagenic|JJ (|(|-LRB- Table|table|NN III|iii|CD )|)|-RRB- .|.|. 
Remarkably|remarkably|RB ,|,|, the|the|DT results|result|NNS of|of|IN each|each|DT four|four|CD testing|testing|NN conditions|condition|NNS per|per|IN compound|compound|NN were|be|VBD almost|almost|RB identical|identical|JJ across|across|IN laboratories|laboratory|NNS as|as|IN 92.5|92.5|CD %|%|NN were|be|VBD concordant|concordant|JJ of|of|IN testing|testing|NN conditions|condition|NNS (|(|-LRB- 37|37|CD of|of|IN 40|40|CD )|)|-RRB- .|.|. 
This|this|DT clearly|clearly|RB indicates|indicate|VBZ that|that|IN bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN assay|assay|NN is|be|VBZ an|a|DT accurate|accurate|JJ ,|,|, efﬁcient|efﬁcient|NN and|and|CC robust|robust|JJ screening|screening|NN tool|tool|NN across|across|IN laboratories|laboratory|NNS .|.|. 
When|when|WRB comparing|compare|VBG individual|individual|JJ experimental|experimental|JJ results|result|NNS with|with|IN previously|previously|RB published|publish|VBN data|datum|NNS by|by|IN the|the|DT NTP|NTP|NNP (|(|-LRB- 2|2|CD --|--|: 6|6|CD )|)|-RRB- ,|,|, the|the|DT concordance|concordance|NN was|be|VBD 87.5|87.5|CD %|%|NN of|of|IN testing|testing|NN conditions|condition|NNS (|(|-LRB- 35|35|CD of|of|IN 40|40|CD )|)|-RRB- .|.|. 
These|these|DT ﬁndings|ﬁndings|NNS are|be|VBP in|in|IN agreement|agreement|NN with|with|IN our|we|PRP$ previously|previously|RB published|publish|VBN data|datum|NNS with|with|IN 105|105|CD compounds|compound|NNS (|(|-LRB- 18|18|CD )|)|-RRB- .|.|. 
The|the|DT discrepancies|discrepancy|NNS between|between|IN the|the|DT NTP|ntp|NN and|and|CC the|the|DT bioluminescent|bioluminescent|JJ assay|assay|NN results|result|NNS are|be|VBP likely|likely|JJ to|to|TO be|be|VB caused|cause|VBN by|by|IN differences|difference|NNS of|of|IN experimental|experimental|JJ procedures|procedure|NNS (|(|-LRB- i.e.|i.e.|FW pre-incubation|pre-incubation|NN in|in|IN NTP|NTP|NNP versus|versus|CC layered|layer|VBN protocol|protocol|NN in|in|IN bioluminescent|bioluminescent|JJ assays|assay|NNS and|and|CC /|/|HYPH purity|purity|NN grades|grade|NNS in|in|IN chemicals|chemical|NNS )|)|-RRB- .|.|. 
In|in|IN summary|summary|NN ,|,|, this|this|DT inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN was|be|VBD conducted|conduct|VBN with|with|IN ﬁve|ﬁve|NN participating|participate|VBG laboratories|laboratory|NNS testing|test|VBG 10|10|CD model|model|NN compounds|compound|NNS .|.|. 
The|the|DT results|result|NNS showed|show|VBD an|a|DT excellent|excellent|JJ agreement|agreement|NN of|of|IN data|datum|NNS across|across|IN all|all|DT ﬁve|ﬁve|NN participating|participate|VBG laboratories|laboratory|NNS .|.|. 
There|there|EX was|be|VBD 100|100|CD %|%|NN agreement|agreement|NN of|of|IN the|the|DT compounds|compound|NNS (|(|-LRB- 10|10|CD of|of|IN 10|10|CD )|)|-RRB- in|in|IN identiﬁcation|identiﬁcation|NN of|of|IN mutagenic|mutagenic|JJ compounds|compound|NNS among|among|IN all|all|DT ﬁve|ﬁve|FW inter-laboratory|inter-laboratory|JJ sites|site|NNS and|and|CC published|publish|VBN NTP|NTP|NNP data|datum|NNS .|.|. 
The|the|DT results|result|NNS of|of|IN this|this|DT inter-laboratory|inter-laboratory|JJ evaluation|evaluation|NN study|study|NN provide|provide|VBP additional|additional|JJ evidence|evidence|NN that|that|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN assay|assay|NN is|be|VBZ a|a|DT robust|robust|JJ ,|,|, highly|highly|RB reproducible|reproducible|JJ and|and|CC accurate|accurate|JJ mutagenicity|mutagenicity|NN screen|screen|NN applicable|applicable|JJ in|in|IN early|early|JJ drug|drug|NN discovery|discovery|NN .|.|. 
Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS )|)|-RRB- (|(|-LRB- A|a|DT An|a|DT th|th|IN racene|racene|NN 20.0|20.0|CD TA98|ta98|NN -|-|HYPH lux|lux|NN -|-|HYPH S9|s9|NN 50.0|50.0|CD TA100|ta100|NN -|-|HYPH lux|lux|NN -|-|HYPH S9|s9|NN 40.0|40.0|CD 30.0|30.0|CD 20.0|20.0|CD 10.0|10.0|CD 0.0|0.0|CD 0.01|0.01|CD 20.0|20.0|CD TA98|ta98|NN -|-|HYPH lux|lux|NN +|+|SYM S9|s9|NN 15.0|15.0|CD 50.0|50.0|CD TA|ta|NN 40.0|40.0|CD 30.0|30.0|CD 20.0|20.0|CD 100|100|CD -|-|HYPH lux|lux|NN +|+|SYM S9|s9|NN 15.0|15.0|CD 10.0|10.0|CD 10.0|10.0|CD 5.0|5.0|CD 5.0|5.0|CD 10.0|10.0|CD 0.0|0.0|CD 0.0|0.0|CD 0.0|0.0|CD 0.01|0.01|CD 1|1|CD 0.1|0.1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 10|10|CD 10|10|CD 0.01|0.01|CD 0|0|CD 0.01|0.01|CD 0|0|CD (|(|-LRB- B|b|NN )|)|-RRB- Benzylchloride|Benzylchloride|NNP 50.0|50.0|CD 20.0|20.0|CD 20.0|20.0|CD 50.0|50.0|CD 40.0|40.0|CD 30.0|30.0|CD 20.0|20.0|CD 10.0|10.0|CD 0.0|0.0|CD 0.01|0.01|CD 40.0|40.0|CD 30.0|30.0|CD 20.0|20.0|CD 10.0|10.0|CD 0.0|0.0|CD 0.01|0.01|CD 15.0|15.0|CD 15.0|15.0|CD 10.0|10.0|CD 10.0|10.0|CD 5.0|5.0|CD 5.0|5.0|CD 0.0|0.0|CD 0.0|0.0|CD 0|0|CD 0.01|0.01|CD 0.1|0.1|CD 0.01|0.01|CD 1|1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 0|0|CD 10|10|CD 10|10|CD )|)|-RRB- (|(|-LRB- C|c|NN Crystalviolet|crystalviolet|NN 50.0|50.0|CD 20.0|20.0|CD 20.0|20.0|CD 50.0|50.0|CD 40.0|40.0|CD 40.0|40.0|CD 30.0|30.0|CD 20.0|20.0|CD 10.0|10.0|CD 15.0|15.0|CD 15.0|15.0|CD 30.0|30.0|CD 20.0|20.0|CD 10.0|10.0|CD Num|num|NN Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS ber|ber|IN of|of|IN revertants|revertant|NNS 10.0|10.0|CD 10.0|10.0|CD 5.0|5.0|CD 5.0|5.0|CD 0.0|0.0|NN 0.0|0.0|NN 0.0|0.0|NN 0.0|0.0|NN 10|10|CD -|-|HYPH 5|5|CD 10|10|CD -|-|HYPH 4|4|CD 10|10|CD -|-|HYPH 3|3|CD 10|10|CD -|-|HYPH 2|2|CD 10|10|CD -|-|HYPH 1|1|CD 10|10|CD -|-|HYPH 5|5|CD 10|10|CD -|-|HYPH 4|4|CD 10|10|CD -|-|HYPH 3|3|CD 10|10|CD -|-|HYPH 2|2|CD 10|10|CD -|-|HYPH 1|1|CD 10|10|CD -|-|HYPH 5|5|CD 10|10|CD -|-|HYPH 4|4|CD 10|10|CD -|-|HYPH 3|3|CD 10|10|CD -|-|HYPH 2|2|CD 10|10|CD -|-|HYPH 1|1|CD 10|10|CD -|-|HYPH 6|6|CD 10|10|CD -|-|HYPH 5|5|CD 10|10|CD -|-|HYPH 4|4|CD 10|10|CD -|-|HYPH 3|3|CD 10|10|CD -|-|HYPH 2|2|CD 10|10|CD -|-|HYPH 1|1|CD Concentration|concentration|NN [|[|-LRB- mg|mg|NN /|/|SYM plate|plate|NN ]|]|-RRB- Concentration|concentration|NN [|[|-LRB- mg|mg|NN /|/|SYM plate|plate|NN ]|]|-RRB- Concentration|concentration|NN [|[|-LRB- mg|mg|NN /|/|SYM plate|plate|NN ]|]|-RRB- Concentration|concentration|NN [|[|-LRB- mg|mg|NN /|/|SYM plate|plate|NN ]|]|-RRB- Fig.|fig.|NN 1|1|CD .|.|. 
Inter-laboratory|inter-laboratory|JJ evaluations|evaluation|NNS of|of|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutagen|mutagen|NN assay|assay|NN demonstrating|demonstrate|VBG concordant|concordant|JJ negative|negative|JJ responses|response|NNS of|of|IN three|three|CD compounds|compound|NNS in|in|IN all|all|DT ﬁve|ﬁve|NN sites|site|NNS :|:|: GTN|gtn|NN --|--|: open|open|JJ circles|circle|NNS ,|,|, NAG|nag|NN --|--|: open|open|JJ squares|square|NNS ,|,|, CAM|cam|NN --|--|: open|open|JJ triangles|triangle|NNS ,|,|, SDW|sdw|NN --|--|: ﬁlled|ﬁlled|VBN squares|square|NNS and|and|CC LJ|LJ|NNP --|--|: ﬁlled|ﬁlled|VBN triangles|triangle|NNS .|.|. 
Individual|individual|JJ values|value|NNS represent|represent|VBP average|average|NN of|of|IN three|three|CD independent|independent|JJ experiments|experiment|NNS with|with|IN SEM|sem|NN (|(|-LRB- standard|standard|JJ error|error|NN mean|mean|NN )|)|-RRB- .|.|. 
Evaluation|evaluation|NN criteria|criterion|NNS for|for|IN positive|positive|JJ responses|response|NNS :|:|: dose|dose|NN dependent|dependent|JJ ,|,|, statistically|statistically|RB signiﬁcant|signiﬁcant|JJ (|(|-LRB- P|p|NN 0.05|0.05|CD )|)|-RRB- ,|,|, 2.0-fold|2.0-fold|RB increase|increase|NN of|of|IN revertant|revertant|NN colonies|colony|NNS over|over|IN untreated|untreated|JJ (|(|-LRB- negative|negative|JJ )|)|-RRB- controls|control|NNS .|.|. 
Nitrofurazone|Nitrofurazone|NNP (|(|-LRB- A|A|NNP )|)|-RRB- 20.0|20.0|CD TA98|ta98|NN -|-|HYPH lux|lux|NN +|+|SYM S9|s9|NN TA100|ta100|NN -|-|HYPH lux|lux|NN +|+|SYM S9|s9|NN TA100|ta100|NN -|-|HYPH lux|lux|NN -|-|HYPH S9|s9|NN Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS TA98|ta98|NN -|-|HYPH lux|lux|NN -|-|HYPH S9|s9|NN 20.0|20.0|CD 100.0|100.0|CD 80.0|80.0|CD 100.0|100.0|CD 80.0|80.0|CD 15.0|15.0|CD 15.0|15.0|CD 60.0|60.0|CD 40.0|40.0|CD 60.0|60.0|CD 40.0|40.0|CD 10.0|10.0|CD 10.0|10.0|CD 5.0|5.0|CD 5.0|5.0|CD 20.0|20.0|CD 0.0|0.0|CD 20.0|20.0|CD 0.0|0.0|CD 0.0|0.0|CD 0.0|0.0|CD 0.0001|0.0001|CD 0.001|0.001|CD 0.01|0.01|CD 0.1|0.1|CD 1|1|CD 1|1|CD 1|1|CD 1|1|CD 0.0001|0.0001|CD 0.001|0.001|CD 0.01|0.01|CD 0.1|0.1|CD 0.0001|0.0001|CD 0.0001|0.0001|CD 0.001|0.001|CD 0.01|0.01|CD 0.1|0.1|CD 0.001|0.001|CD 0.01|0.01|CD 0.1|0.1|CD (|(|-LRB- B|b|NN )|)|-RRB- Benzo|benzo|NN [|[|-LRB- a|a|DT ]|]|-RRB- pyrene|pyrene|JJ 25.0|25.0|CD 20.0|20.0|CD 25.0|25.0|CD 20.0|20.0|CD 50.0|50.0|CD 40.0|40.0|CD 50.0|50.0|CD 40.0|40.0|CD 15.0|15.0|CD 10.0|10.0|CD 15.0|15.0|CD 10.0|10.0|CD 30.0|30.0|CD 20.0|20.0|CD 30.0|30.0|CD 20.0|20.0|CD 5.0|5.0|CD 0.0|0.0|CD 10.0|10.0|CD 10.0|10.0|CD 0.0|0.0|CD 0.01|0.01|CD 5.0|5.0|CD 0.0|0.0|NN 0.0|0.0|NN 0.1|0.1|CD 0.01|0.01|CD 0|0|CD 0.01|0.01|CD 1|1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 10|10|CD 0.1|0.1|CD 1|1|CD 10|10|CD 10|10|CD 0.01|0.01|CD (|(|-LRB- C|c|NN )|)|-RRB- 1,4|1,4|CD -|-|HYPH benzoquinone|benzoquinone|NN 60.0|60.0|CD 50.0|50.0|CD 60.0|60.0|CD 50.0|50.0|CD 60.0|60.0|CD 50.0|50.0|CD 60.0|60.0|CD 50.0|50.0|CD 40.0|40.0|CD 30.0|30.0|CD 40.0|40.0|CD 30.0|30.0|CD 40.0|40.0|CD 30.0|30.0|CD 40.0|40.0|CD 30.0|30.0|CD 20.0|20.0|CD 10.0|10.0|CD 20.0|20.0|CD 10.0|10.0|CD 20.0|20.0|CD 10.0|10.0|CD 20.0|20.0|CD 10.0|10.0|CD 0.0|0.0|NN 0.0|0.0|NN 0.0|0.0|NN 0.0|0.0|NN 0.1|0.1|CD 0|0|CD 0.01|0.01|CD 1|1|CD 0.01|0.01|CD 0.1|0.1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 10|10|CD 0.1|0.1|CD 10|10|CD 1|1|CD 0.01|0.01|CD 10|10|CD 1|1|CD 0.01|0.01|CD (|(|-LRB- D|d|NN )|)|-RRB- itroph|itroph|NN o|o|IN -5-n|-5-n|NN 2|2|CD -|-|HYPH amin|amin|NN en|en|FW ol|ol|FW Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS Number|number|NN of|of|IN revertants|revertant|NNS 10.0|10.0|CD 8.0|8.0|CD 40.0|40.0|CD 50.0|50.0|CD 40.0|40.0|CD 50.0|50.0|CD 40.0|40.0|CD 30.0|30.0|CD 6.0|6.0|CD 4.0|4.0|CD 30.0|30.0|CD 20.0|20.0|CD 30.0|30.0|CD 20.0|20.0|CD 20.0|20.0|CD 10.0|10.0|CD 2.0|2.0|CD 0.0|0.0|CD 10.0|10.0|CD 0.0|0.0|CD 0.01|0.01|CD 10.0|10.0|CD 0.0|0.0|CD 0.01|0.01|CD 0.0|0.0|CD 0.1|0.1|CD 0.01|0.01|CD 10|10|CD 0|0|CD 0.01|0.01|CD 1|1|CD 0.1|0.1|CD 1|1|CD 1|1|CD 0.1|0.1|CD 1|1|CD 10|10|CD 0.1|0.1|CD 1|1|CD 10|10|CD (|(|-LRB- E|e|NN )|)|-RRB- 20.0|20.0|CD Busulfan|Busulfan|NNP 70.0|70.0|CD 60.0|60.0|CD 70.0|70.0|CD 60.0|60.0|CD 20.0|20.0|CD 15.0|15.0|CD 15.0|15.0|CD 50.0|50.0|CD 40.0|40.0|CD 30.0|30.0|CD 20.0|20.0|CD 10.0|10.0|CD 0.0|0.0|CD 0.01|0.01|CD 0.1|0.1|CD 1|1|CD Concentration|concentration|NN [|[|-LRB- mg|mg|NN /|/|SYM plate|plate|NN ]|]|-RRB- 50.0|50.0|CD 40.0|40.0|CD 30.0|30.0|CD 20.0|20.0|CD 10.0|10.0|CD 0.0|0.0|CD 0.01|0.01|CD 0.1|0.1|CD 1|1|CD Concentration|concentration|NN [|[|-LRB- mg|mg|NN /|/|SYM plate|plate|NN ]|]|-RRB- 10.0|10.0|CD 10.0|10.0|CD 5.0|5.0|CD 5.0|5.0|CD 0.0|0.0|CD 0.0|0.0|CD 0.01|0.01|CD 0.1|0.1|CD 1|1|CD Concentration|concentration|NN [|[|-LRB- mg|mg|NN /|/|SYM plate|plate|NN ]|]|-RRB- 0.01|0.01|CD 0.1|0.1|CD 1|1|CD Concentration|concentration|NN [|[|-LRB- mg|mg|NN /|/|SYM plate|plate|NN ]|]|-RRB- 10|10|CD 10|10|CD 10|10|CD 10|10|CD Fig.|fig.|NN 2|2|CD .|.|. 
Inter-laboratory|inter-laboratory|JJ evaluations|evaluation|NNS of|of|IN the|the|DT bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutagen|mutagen|NN assay|assay|NN demonstrating|demonstrate|VBG concordant|concordant|JJ positive|positive|JJ responses|response|NNS of|of|IN ﬁve|ﬁve|NN compounds|compound|NNS in|in|IN all|all|DT ﬁve|ﬁve|NN sites|site|NNS :|:|: GTN|gtn|NN --|--|: open|open|JJ circles|circle|NNS ,|,|, NAG|nag|NN --|--|: open|open|JJ squares|square|NNS ,|,|, CAM|cam|NN --|--|: open|open|JJ triangles|triangle|NNS ,|,|, SDW|sdw|NN --|--|: ﬁlled|ﬁlled|VBN squares|square|NNS and|and|CC LJ|LJ|NNP --|--|: ﬁlled|ﬁlled|VBN triangles|triangle|NNS .|.|. 
Individual|individual|JJ values|value|NNS represent|represent|VBP average|average|NN of|of|IN three|three|CD independent|independent|JJ experiments|experiment|NNS with|with|IN SEM|sem|NN (|(|-LRB- standard|standard|JJ error|error|NN mean|mean|NN )|)|-RRB- .|.|. 
Evaluation|evaluation|NN criteria|criterion|NNS for|for|IN positive|positive|JJ responses|response|NNS :|:|: dose|dose|NN dependent|dependent|JJ ,|,|, statistically|statistically|RB signiﬁcant|signiﬁcant|JJ (|(|-LRB- P|p|NN 0.05|0.05|CD )|)|-RRB- ,|,|, 2.0-fold|2.0-fold|RB increase|increase|NN of|of|IN revertant|revertant|NN colonies|colony|NNS over|over|IN untreated|untreated|JJ (|(|-LRB- negative|negative|JJ )|)|-RRB- controls|control|NNS .|.|. 
(|(|-LRB- Table|table|NN I|i|NN )|)|-RRB- was|be|VBD the|the|DT smallest|smallest|JJS (|(|-LRB- 5.9|5.9|CD revertants|revertant|NNS per|per|IN plate|plate|NN )|)|-RRB- .|.|. 
Therefore|therefore|RB ,|,|, we|we|PRP recommend|recommend|VBP keeping|keep|VBG the|the|DT optimal|optimal|JJ level|level|NN of|of|IN background|background|NN revertants|revertant|NNS with|with|IN TA100|ta100|NN -|-|HYPH lux|lux|NN in|in|IN the|the|DT range|range|NN of|of|IN 7|7|CD --|--|: 15|15|CD revertants|revertant|NNS per|per|IN plate|plate|NN .|.|. 
In|in|IN the|the|DT case|case|NN of|of|IN TA98|ta98|NN -|-|HYPH lux|lux|NN ,|,|, the|the|DT lower|lower|JJR background|background|NN in|in|IN comparison|comparison|NN with|with|IN TA100|ta100|NN -|-|HYPH lux|lux|NN reﬂects|reﬂects|VBZ the|the|DT similar|similar|JJ ratio|ratio|NN as|as|IN when|when|WRB comparing|compare|VBG their|they|PRP$ parental|parental|JJ strains|strain|NNS TA100|ta100|NN and|and|CC TA98|ta98|NN .|.|. 
To|to|TO eliminate|eliminate|VB the|the|DT inﬂuence|inﬂuence|NN of|of|IN the|the|DT low|low|JJ background|background|NN ,|,|, we|we|PRP used|use|VBD a|a|DT default|default|NN 1.5|1.5|CD revertants|revertant|NNS per|per|IN well|well|NN as|as|IN background|background|NN for|for|IN all|all|DT experiments|experiment|NNS that|that|WDT where|where|WRB ,1.5|,1.5|NN .|.|. 
Utilizing|utilize|VBG this|this|DT default|default|NN does|do|VBZ not|not|RB inﬂuence|inﬂuence|VB the|the|DT interpretation|interpretation|NN of|of|IN the|the|DT data|datum|NNS .|.|. 
Overall|overall|RB ,|,|, there|there|EX was|be|VBD 100|100|CD %|%|NN agreement|agreement|NN of|of|IN the|the|DT compounds|compound|NNS (|(|-LRB- 10|10|CD of|of|IN 10|10|CD )|)|-RRB- among|among|IN testing|testing|NN laboratories|laboratory|NNS and|and|CC previously|previously|RB published|publish|VBN data|datum|NNS Acknowledgements|acknowledgement|NNS We|we|PRP thank|thank|VBP the|the|DT following|follow|VBG Groton|Groton|NNP colleagues|colleague|NNS :|:|: Jennifer|Jennifer|NNP Cheung|Cheung|NNP ,|,|, Michelle|Michelle|NNP Kenyon|Kenyon|NNP and|and|CC Jeff|Jeff|NNP Osowski|Osowski|NNP with|with|IN their|they|PRP$ strong|strong|JJ technical|technical|JJ participation|participation|NN in|in|IN this|this|DT study|study|NN and|and|CC Jennifer|Jennifer|NNP Kispert|Kispert|NNP and|and|CC Krista|Krista|NNP Dobo|Dobo|NNP with|with|IN their|they|PRP$ comments|comment|NNS and|and|CC suggestions|suggestion|NNS for|for|IN this|this|DT manuscript|manuscript|NN .|.|. 
References|reference|NNS 1|1|CD .|.|. 
Ames|Ames|NNP ,|,|, B.|B.|NNP N.|N.|NNP ,|,|, Durston|Durston|NNP ,|,|, W.|W.|NNP E.|E.|NNP ,|,|, Yamasaki|Yamasaki|NNP ,|,|, E.|E.|NNP and|and|CC Lee|Lee|NNP ,|,|, F.|F.|NNP D.|D.|NNP (|(|-LRB- 1973|1973|CD )|)|-RRB- Carcinogens|carcinogen|NNS are|be|VBP mutagens|mutagen|NNS .|.|. 
Simple|simple|JJ test|test|NN system|system|NN combining|combine|VBG liver|liver|NN homogenates|homogenate|NNS for|for|IN activation|activation|NN and|and|CC bacteria|bacterium|NNS for|for|IN detection|detection|NN .|.|. 
Proc|Proc|NNP .|.|. 
Natl|Natl|NNP Acad|Acad|NNP .|.|. 
Sci|sci|NN .|.|. 
USA|USA|NNP ,|,|, 70|70|CD ,|,|, 2281|2281|CD --|--|: 2285|2285|CD .|.|. 
2|2|LS .|.|. 
Haworth|Haworth|NNP ,|,|, S.|S.|NNP ,|,|, Lawlor|Lawlor|NNP ,|,|, T.|T.|NNP ,|,|, Mortelmans|Mortelmans|NNP ,|,|, K.|K.|NNP ,|,|, Speck|Speck|NNP ,|,|, W.|W.|NNP and|and|CC Zeiger|Zeiger|NNP ,|,|, E.|E.|NNP (|(|-LRB- 1983|1983|CD )|)|-RRB- Salmonella|salmonella|NN mutagenicity|mutagenicity|NN test|test|NN results|result|NNS for|for|IN 250|250|CD chemicals|chemical|NNS .|.|. 
Environ|Environ|NNP .|.|. 
Mutagen|mutagen|NN .|.|. 
,|,|, 5|5|CD ,|,|, 3|3|CD --|--|: 142|142|CD .|.|. 
3|3|LS .|.|. 
Mortelmans|Mortelmans|NNP ,|,|, K.|K.|NNP ,|,|, Haworth|Haworth|NNP ,|,|, S.|S.|NNP ,|,|, Lawlor|Lawlor|NNP ,|,|, T.|T.|NNP ,|,|, Speck|Speck|NNP ,|,|, W.|W.|NNP ,|,|, Tainer|Tainer|NNP ,|,|, B.|B.|NNP and|and|CC Zeiger|Zeiger|NNP ,|,|, E.|E.|NNP (|(|-LRB- 1986|1986|CD )|)|-RRB- Salmonella|salmonella|NN mutagenicity|mutagenicity|NN tests|test|NNS :|:|: II|ii|CD .|.|. 
Results|result|NNS from|from|IN the|the|DT testing|testing|NN of|of|IN 270|270|CD chemicals|chemical|NNS .|.|. 
Environ|Environ|NNP .|.|. 
Mutagen|mutagen|NN .|.|. 
,|,|, 8|8|CD ,|,|, 1|1|CD --|--|: 119|119|CD .|.|. 
4|4|LS .|.|. 
Zeiger|Zeiger|NNP ,|,|, E.|E.|NNP ,|,|, Anderson|Anderson|NNP ,|,|, B.|B.|NNP ,|,|, Haworth|Haworth|NNP ,|,|, S.|S.|NNP ,|,|, Lawlor|Lawlor|NNP ,|,|, T.|T.|NNP and|and|CC Mortelmans|Mortelmans|NNPS ,|,|, K.|K.|NNP (|(|-LRB- 1988|1988|CD )|)|-RRB- Salmonella|salmonella|NN mutagenicity|mutagenicity|NN tests|test|NNS :|:|: IV|iv|CD .|.|. 
Results|result|NNS from|from|IN the|the|DT testing|testing|NN of|of|IN 300|300|CD chemicals|chemical|NNS .|.|. 
Environ|Environ|NNP .|.|. 
Mol|Mol|NNP .|.|. 
Mutagen|mutagen|NN .|.|. 
,|,|, 11|11|CD ,|,|, 1|1|CD --|--|: 157|157|CD .|.|. 
5|5|CD .|.|. 
Zeiger|Zeiger|NNP ,|,|, E.|E.|NNP ,|,|, Anderson|Anderson|NNP ,|,|, B.|B.|NNP ,|,|, Haworth|Haworth|NNP ,|,|, S.|S.|NNP ,|,|, Lawlor|Lawlor|NNP ,|,|, T.|T.|NNP and|and|CC Mortelmans|Mortelmans|NNPS ,|,|, K.|K.|NNP (|(|-LRB- 1992|1992|CD )|)|-RRB- Salmonella|salmonella|NN mutagenicity|mutagenicity|NN tests|test|NNS :|:|: V.|V.|NNP Results|result|NNS from|from|IN the|the|DT testing|testing|NN of|of|IN 311|311|CD chemicals|chemical|NNS .|.|. 
Environ|Environ|NNP .|.|. 
Mol|Mol|NNP .|.|. 
Mutagen|mutagen|NN .|.|. 
,|,|, 19|19|CD ,|,|, 2|2|CD --|--|: 141|141|CD .|.|. 
6|6|CD .|.|. 
Zeiger|Zeiger|NNP ,|,|, E.|E.|NNP ,|,|, Anderson|Anderson|NNP ,|,|, B.|B.|NNP ,|,|, Haworth|Haworth|NNP ,|,|, S.|S.|NNP ,|,|, Lawlor|Lawlor|NNP ,|,|, T.|T.|NNP and|and|CC Mortelmans|Mortelmans|NNPS ,|,|, K.|K.|NNP (|(|-LRB- 1987|1987|CD )|)|-RRB- Salmonella|salmonella|NN mutagenicity|mutagenicity|NN tests|test|NNS III|iii|CD .|.|. 
Results|result|NNS from|from|IN the|the|DT testing|testing|NN of|of|IN 255|255|CD chemicals|chemical|NNS .|.|. 
Environ|Environ|NNP .|.|. 
Mutagen|mutagen|NN .|.|. 
,|,|, 9|9|CD ,|,|, 1|1|CD --|--|: 109|109|CD .|.|. 
7|7|CD .|.|. 
Kim|Kim|NNP ,|,|, B.|B.|NNP S.|S.|NNP and|and|CC Margolin|Margolin|NNP ,|,|, B.|B.|NNP H.|H.|NNP (|(|-LRB- 1999|1999|CD )|)|-RRB- Prediction|prediction|NN of|of|IN rodent|rodent|NN carcinogenicity|carcinogenicity|NN utilizing|utilize|VBG a|a|DT battery|battery|NN of|of|IN in|in|FW vitro|vitro|FW and|and|CC in|in|FW vivo|vivo|FW genotoxicity|genotoxicity|NN tests|test|NNS .|.|. 
Environ|Environ|NNP .|.|. 
Mutagen|mutagen|NN .|.|. 
,|,|, 34|34|CD ,|,|, 297|297|CD --|--|: 304|304|CD .|.|. 
8|8|CD .|.|. 
Zeiger|Zeiger|NNP ,|,|, E.|E.|NNP (|(|-LRB- 1998|1998|CD )|)|-RRB- Identiﬁcation|identiﬁcation|NN of|of|IN rodent|rodent|NN carcinogens|carcinogen|NNS and|and|CC noncarcinogens|noncarcinogen|NNS using|use|VBG genetic|genetic|JJ toxicity|toxicity|NN tests|test|NNS :|:|: premises|premise|NNS ,|,|, promises|promise|NNS ,|,|, and|and|CC performance|performance|NN .|.|. 
Regul|Regul|NNP .|.|. 
Toxicol|Toxicol|NNP .|.|. 
Pharmacol|Pharmacol|NNP .|.|. 
,|,|, 28|28|CD ,|,|, 85|85|CD --|--|: 95|95|CD .|.|. 
9|9|LS .|.|. 
Muller|Muller|NNP ,|,|, L.|L.|NNP ,|,|, Kikuchi|Kikuchi|NNP ,|,|, Y.|Y.|NNP ,|,|, Probst|Probst|NNP ,|,|, G.|G.|NNP ,|,|, Schechtman|Schechtman|NNP ,|,|, L.|L.|NNP ,|,|, Shimada|Shimada|NNP ,|,|, H.|H.|NNP ,|,|, Sofuni|Sofuni|NNP ,|,|, T.|T.|NNP and|and|CC Tweats|Tweats|NNP ,|,|, D.|D.|NNP (|(|-LRB- 1999|1999|CD )|)|-RRB- ICH|ich|NN -|-|HYPH harmonised|harmonise|VBN guidances|guidance|NNS on|on|IN genotoxicity|genotoxicity|NN testing|testing|NN of|of|IN pharmaceuticals|pharmaceutical|NNS :|:|: evolution|evolution|NN ,|,|, reasoning|reasoning|NN ,|,|, and|and|CC impact|impact|NN .|.|. 
Mutat|Mutat|NNP .|.|. 
Res|re|NNS .|.|. 
,|,|, 436|436|CD ,|,|, 195|195|CD --|--|: 225|225|CD .|.|. 
10|10|CD .|.|. 
Snyder|Snyder|NNP ,|,|, R.|R.|NNP D.|D.|NNP and|and|CC Green|Green|NNP ,|,|, J.|J.|NNP W.|W.|NNP (|(|-LRB- 2001|2001|CD )|)|-RRB- A|a|DT review|review|NN of|of|IN the|the|DT genotoxicity|genotoxicity|NN of|of|IN marketed|market|VBN pharmaceuticals|pharmaceutical|NNS .|.|. 
Mutat|Mutat|NNP .|.|. 
Res|re|NNS .|.|. 
,|,|, 488|488|CD ,|,|, 151|151|CD --|--|: 169|169|CD .|.|. 
11|11|CD .|.|. 
Burke|Burke|NNP ,|,|, D.|D.|NNP A.|A.|NNP ,|,|, Wedd|Wedd|NNP ,|,|, D.|D.|NNP J.|J.|NNP and|and|CC Burlinson|Burlinson|NNP ,|,|, B.|B.|NNP (|(|-LRB- 1996|1996|CD )|)|-RRB- Use|use|NN of|of|IN the|the|DT Miniscreen|Miniscreen|NNP assay|assay|NN to|to|TO screen|screen|VB novel|novel|JJ compounds|compound|NNS for|for|IN bacterial|bacterial|JJ mutagenicity|mutagenicity|NN in|in|IN the|the|DT pharmaceutical|pharmaceutical|JJ industry|industry|NN .|.|. 
Mutagenesis|mutagenesis|NN ,|,|, 11|11|CD ,|,|, 201|201|CD --|--|: 205|205|CD .|.|. 
12|12|CD .|.|. 
Houk|Houk|NNP ,|,|, V.|V.|NNP S.|S.|NNP ,|,|, Schalkowsky|Schalkowsky|NNP ,|,|, S.|S.|NNP and|and|CC Claxton|Claxton|NNP ,|,|, L.|L.|NNP D.|D.|NNP (|(|-LRB- 1989|1989|CD )|)|-RRB- Development|development|NN and|and|CC validation|validation|NN of|of|IN the|the|DT spiral|spiral|JJ salmonella|salmonella|NN assay|assay|NN :|:|: an|a|DT automated|automate|VBN approach|approach|NN to|to|IN bacterial|bacterial|JJ mutagenicity|mutagenicity|NN testing|testing|NN .|.|. 
Mutat|Mutat|NNP .|.|. 
Res|re|NNS .|.|. 
,|,|, 223|223|CD ,|,|, 49|49|CD --|--|: 64|64|CD .|.|. 
13|13|CD .|.|. 
Brooks|Brooks|NNP ,|,|, T.|T.|NNP M.|M.|NNP (|(|-LRB- 1995|1995|CD )|)|-RRB- The|the|DT use|use|NN of|of|IN a|a|DT streamlined|streamlined|JJ bacterial|bacterial|JJ mutagenicity|mutagenicity|NN assay|assay|NN ,|,|, the|the|DT MINISCREEN|MINISCREEN|NNP .|.|. 
Mutagenesis|mutagenesis|NN ,|,|, 10|10|CD ,|,|, 447|447|CD --|--|: 448|448|CD .|.|. 
14|14|CD .|.|. 
Falck|Falck|NNP ,|,|, K.|K.|NNP ,|,|, Partanen|Partanen|NNP ,|,|, P.|P.|NNP ,|,|, Sorsa|Sorsa|NNP ,|,|, M.|M.|NNP ,|,|, Suovaniemi|Suovaniemi|NNP ,|,|, O.|O.|NNP and|and|CC Vainio|Vainio|NNP ,|,|, H.|H.|NNP (|(|-LRB- 1985|1985|CD )|)|-RRB- Mutascreen|Mutascreen|NNP ,|,|, an|a|DT automated|automate|VBN bacterial|bacterial|JJ mutagenicity|mutagenicity|NN assay|assay|NN .|.|. 
Mutat|Mutat|NNP .|.|. 
Res|re|NNS .|.|. 
,|,|, 150|150|CD ,|,|, 119|119|CD --|--|: 125|125|CD .|.|. 
15|15|CD .|.|. 
Gee|gee|NN ,|,|, P.|P.|NNP ,|,|, Maron|Maron|NNP ,|,|, D.|D.|NNP M.|M.|NNP and|and|CC Ames|Ames|NNP ,|,|, B.|B.|NNP N.|N.|NNP (|(|-LRB- 1994|1994|CD )|)|-RRB- Detection|detection|NN and|and|CC classiﬁcation|classiﬁcation|NN of|of|IN mutagens|mutagen|NNS :|:|: a|a|DT set|set|NN of|of|IN base|base|NN -|-|HYPH speciﬁc|speciﬁc|NN Salmonella|salmonella|NN tester|tester|NN strains|strain|NNS .|.|. 
Proc|Proc|NNP .|.|. 
Natl|Natl|NNP Acad|Acad|NNP .|.|. 
Sci|sci|NN .|.|. 
USA|USA|NNP ,|,|, 91|91|CD ,|,|, 11606|11606|CD --|--|: 11610|11610|CD .|.|. 
16|16|CD .|.|. 
Diehl|Diehl|NNP ,|,|, M.|M.|NNP and|and|CC Fort|Fort|NNP ,|,|, F.|F.|NNP (|(|-LRB- 1996|1996|CD )|)|-RRB- Spiral|spiral|JJ Salmonella|salmonella|NN assay|assay|NN :|:|: validation|validation|NN against|against|IN the|the|DT standard|standard|NN pour|pour|VB -|-|HYPH plate|plate|NN assay|assay|NN .|.|. 
Environ|Environ|NNP .|.|. 
Mol|Mol|NNP .|.|. 
Mutagen|mutagen|NN .|.|. 
,|,|, 27|27|CD ,|,|, 227|227|CD --|--|: 236|236|CD .|.|. 
17|17|CD .|.|. 
Diehl|Diehl|NNP ,|,|, M.|M.|NNP S.|S.|NNP ,|,|, Willaby|Willaby|NNP ,|,|, S.|S.|NNP L.|L.|NNP and|and|CC Snyder|Snyder|NNP ,|,|, R.|R.|NNP D.|D.|NNP (|(|-LRB- 2000|2000|CD )|)|-RRB- Comparison|comparison|NN of|of|IN the|the|DT results|result|NNS of|of|IN a|a|DT modiﬁed|modiﬁed|JJ miniscreen|miniscreen|NN and|and|CC the|the|DT standard|standard|JJ bacterial|bacterial|JJ reverse|reverse|JJ mutation|mutation|NN assays|assay|NNS .|.|. 
Environ|Environ|NNP .|.|. 
Mol|Mol|NNP .|.|. 
Mutagen|mutagen|NN .|.|. 
,|,|, 36|36|CD ,|,|, 72|72|CD --|--|: 77|77|CD .|.|. 
18|18|CD .|.|. 
Aubrecht|Aubrecht|NNP ,|,|, J.|J.|NNP ,|,|, Osowski|Osowski|NNP ,|,|, J.|J.|NNP ,|,|, Persaud|Persaud|NNP ,|,|, P.|P.|NNP ,|,|, Cheung|Cheung|NNP ,|,|, J.|J.|NNP ,|,|, Ackerman|Ackerman|NNP ,|,|, J.|J.|NNP ,|,|, Lopes|Lopes|NNP ,|,|, S.|S.|NNP H.|H.|NNP and|and|CC Ku|Ku|NNP ,|,|, W.|W.|NNP (|(|-LRB- 2007|2007|CD )|)|-RRB- Bioluminescent|bioluminescent|JJ Salmonella|salmonella|NN reverse|reverse|JJ mutation|mutation|NN assay|assay|NN :|:|: a|a|DT screen|screen|NN for|for|IN detecting|detect|VBG mutagenicity|mutagenicity|NN with|with|IN high|high|JJ throughput|throughput|NN attributes|attribute|NNS .|.|. 
Mutagenesis|mutagenesis|NN ,|,|, 22|22|CD ,|,|, 335|335|CD --|--|: 342|342|CD .|.|. 
